

EH


Clinical
dXA
FM
HF pna
molecular

Renal artery_ stenosis
exercise cardiovascular health
tertiary_ referral
devices heart_ failure

Liver_ disease
hospital_ mortality
DESIGN
surgery heart transplant recipients
EC
breathing heart_beat

DESIGN
heart_ failure Latin America

HF
mortality



doctors


Heart

Nutrition heart_ failure
Cross-sectional
unilateral

heart_ failure
interventions

Heart

clin

trans


intermediate_frailty

CHF
dodson


air pollution heart_ failure
cardiovascular disease



temporales HF MI
Heart_ failure
hemostasis
Remote ischemic conditioning heart_ failure
Heart_fréquence
Heart_ failure

rates CHF

Sham-operation_animal
policy



taxonomy

doxorubicin
cell Anand
cox proportional_ hazards
complications
HF
blood transfusions
Heart_ failure bisphosphonates
diuretic_utilisation heart_ failure
caspase heart failure
right_ heart_ failure pulmonary hypertension
benefits cardiovascular
HF
Internal_ reliability cronbach
hypertension



periprocedural
frailty_ in_ heart_ failure
hz afterload_ burden

Hazard cox
RAS atherosclerosis
patient_ safety conditions
PSSS
MicroRNAs heart_ failure disease
heart_ failure
Cardiology inhibition heart_ failure
heart_ failure ejection_fraction
implanted_ monitoring devices
Median_ age

Heart_ failure cognitive impairment mortality
LV fibrosis
cardiology university_hospital
HFpEF
fréquence HF
autonomic balance
HF


inpatient medical conditions
Mitral_ stenosis heart_ failure
median_ follow-up
competitive
CO
heart_ failure cardiovascular death
cognitive_fonctionnel
vasopressin congestive_ heart_ failure
cardiac transplantation
Jehovah_s_ Witness anemia
pde2 HF


black

metric_ choice readmission_ metrics
ET CHF
readmission_metric

physician
Median_ follow-up
Arrhythmia-related costs
Medication sST2
reliability HF
mortality sts hm
réseau_meta-analysis
propensity
mortality random-effects


surgical_ tactiques circulatory_ arrest
CHF
ejection_fraction sex bNP
Chronic_HF
MR MS
HFpEF
Cardiac_amyloidosis
Pigs antiarrhythmic medication
Robot-assisted_training heart_ failure


biomarkers chronic_heart_ failure
Heart_ rate arterial_tension
beta blockade
hgb HRQoL
cardiac inflammatory biomarkers
systolique_ dysfunction
ejection_fraction
HF cardiovascular
heart_ failure
US_ healthcare



abnormal cardiac
drug Japan

risk
VO2max
ESRD
biomarkers
HR HF
mAIN_oUTCOME_measures tug
heart_ failure


Heart ventricular_ ejection_fraction
aortic_tension_curve
heart_ failureHF therapy
physician_continuity discharge
Heart_ failure public_ health
Trastuzumab-related_ cardiotoxicity breast cancer
Nights hospital coprimary outcome
Cardiac
Postoperative_ normalization albumin
Tolvaptan vasopressin receptor
molecular_ scaffolds heart_pathologie
Functional MS degenerative MR
Heart_ failureHF mortality
spironolactone systolique_ heart_ failure
chronic_heart_ failure bisoprolol
cox proportional_ hazards
HF
clinician expertise HF

therapy
circulation
enrollment
cPGs
ms surgery
pathophysiological

AHA ESC
gross_ income expenditure health
heart_ failure
implantation

dialysis implantation
cox proportional_ hazards
survival Seattle_ Heart_ Failure
heart_ failure


Coronary_ angiography
MS surgery echocardiography
Hemodynamic_ phenotype Fontan
off-pump_ sternal_ sparing HeartMate
heart_ failure cox proportional_ hazard
Nordic_ walking
multiorgan_ failure sepsis
Pharmacological_ treatment acute_heart_ failure
kidney injury
endothelial_fonctionnel dilatation
Psychometric_ testing Self-Care_de_ Heart_ Failure

AI surgical
grLS CV
mortality
deficits



nursing
race
QRs benefit
ms surgery
skeletal_ muscle_ abnormalités Fontan_ circulation
renin-angiotensin-aldosterone heart_ failure
CHF unilateral renal DNx cardiac_ autonomic balance
acute_ heart_ failure
anaerobic_ threshold
abnormal HR_ variability cardiac_ death
mAIN_oUTCOME
aac cardiac_ hypertrophy
indices postsystolique
Physician heart_ failure
medication hemodynamics
toxicity blood_tension
patient_ satisfaction
Mitral_regurgitation HF
hospital_ longitudinal change
systolic HF
hospital heart_ failure discharge
heart_ failure
progressive hypertension kidney_ failure
chronic_ kidney_ diseaseCKd
HF
ICU mortality
Nurses disease
cRT dialysis-dependent patients
CHF
RM
économique savings coût
immunohistochemistry electron microscopy
ischemic_ cardiomyopathy sex mortality
idiopathic dilated_ cardiomyopathy
HF chromatin_ hyperacetilation
diastolic_ dysfunction peripheral_ artery disease
cardiac_sodium_ current heart_ failure
angiotensin receptor_ neprilysin_ inhibitor heart_ failure
hypertensive LV dysfunction MR MS
physicians HF
hypoalbuminemia heart_ failure
acute_heart_ failure
avantages anemia

lVAD

services_management telehealth medicare
public reporting
Rhythm- and_ rate-control
sinus rhythm AF

Myocardial infarction Wistar rats
cd HF
heart_ failure cardiac rehabilitation
ingenuity
Race spironolactone heart_ failure
TAC
MS mva
cRF
Mediterranean DASh
social_support exercise
rehospitalization
odds ratios hospital_ clustering
risk hospitalization heart_ failure
nitroxyl hno heart_ failure
hff HFpf
Heart_block pulmonary artery biVP
Blacks VO2
Hospital_to-Home hospital_ readmission_reduction_program congestive_ heart_ failure
Cardiac-resynchronization_therapy heart_ failure
physician_ continuity urgent_ readmission_de_discharge heart_ failure

diabetes e-cFUs

af pacientes echocardiographic
MSHF surgical indication MS
Cardiac_fonctionnel pressure-volume_ conductance catheter
BB therapy
PVf PB amplitude
congenital_ heart_ lesions
beta-blockers
cardiovascular events
MS
diuretic_utilisation HF
CAD systolic HF
bioinformatic
lVET follow-up
resistin inflammation metabolism heart
coronary_ disease heart_ failure
hypoalbuminemia lVAD
signalling_pathways adaptive cardiac remodelling
Fat cachexia ventricle heart_ failure complicity
atrial_ fibrillationAF heart_ failure
deficit biological_ phenotype mortality

avd VVD free wall
ESRD outpatientsHF
Exercise_ intolerance chronic_ heart_ failure
subclinical_atherosclerosis
remodelling HF haemodynamic neuronal stressors
ventricular_fréquence
heart_ transplantation left ventricular_assist device
eCGs electrocardiographers
heart_ rate
safety_ end point
dialysis
fffffffffff body_weightcc
Frailty HF
Cardiac_caxiacc
Southeastern Minnesota hf
multihospital_ study heart_ failure
hff
proteome_de_ HDL particles shotgun LC-MS
branch_block_electrical_activation_sequence
transplant ECCT
Protective effects ed endothelial
CV death_non-fatal_ stroke heart_ failure
ECCT advanced_heart_ failure
hf dp-4 inhibitors drugs
holosystolique_ murmur heart
bromodomain_ proteins
heart_ failure
HF
pharmaceutically_assisted
hypotension
bt DT implantation
mortality
Peak VO2
ST2
discharge medication
septal defects surgical
extubated blood_ loss transfusion
mortality iCD-HF
miRNAs cardiac_pathogenesis
biomarkers HF
preoperative_ clinical mortality

FINDINGs

trastuzumab-related CHF
transplants
Healthy
hospitals
économique
patient_ safety
Wilcoxon signed-rank
ventricular_assist device ventricular_support
psoriasis atherosclerosis cardiovascular events Rotterdam
Renal_ artery_ stenosisRAS peripheral_ arterial
Heart_ failure rheumatoid_arthritis tNF
Coronary_ artery diseaseCAD systolique_ heart_ failureHF
mortalityHF hospital_admissions transplant ventricular_assist device
validity
hospitals
heart_ failure ejection_fraction
renal_ denervation autonomic_ balance rabbits heart_ failure
regulatory_subunitRI HF
Nfat mir-25 transcription_factor Hand2 heart_ failure
VEGF_ inhibition b cardiac remodeling
Myxomas right_ atrium pulmonary_ arterial
Right_ atrial_Myxoma pulmonary_ embolism right_ heart_ failure
Orthotopic_ heart_ transplantation oHT end-stage_heart_ failure
coronary_ heart_ disease stroke heart_ failure
β-blockerBB sST2
eplerenone
cPET_guiding_ exercise CHF
ECCT cardiac transplant
technique malfunctioning HeartMate_ II lVADs
Heart_ failureHF cardiovascular
medications heart_ failure

MLHF
Patients heart_ failure medication
resistin decline ejection_fraction
Pediatric heart_ failureHF morbidity mortality
readmissions heart_ failure
ischemic_inflammatory_ abdominal
caspase paced_Myocardium
aCR CMS
MedLine EMBAse cINAHL
renal_ dysfunction transplant morbidity
anemia heart_ disease
Heart_ failure_ disease
hf saxagliptin sitagliptin

dysfunction pump_ failure driveline_ injury pump
HF
hospital_discharge
Renal DNx circulation_ plasma CHF-inv rabbits
hct germline_DNA genotyped
implantation
CAD



HDL-bound_ malondialdehyde HDL-induced EC
trastuzumab
NP
HF
EH hpEF
Soluble_ ST2 ambulatory patients heart_ failure
hospital_discharge patients_with_heart_ failure
echocardiograms reverse remodeling
Titin_hyphosphorylation myocardial DD
Cardiac Mammalian mena heart_ failure mice
canine_model_de_ chronic_ heart_ failure tachycardia
RAS- β-blocker_uptitration HFpEF
coronary_ artery diseaseCAD
LV filling_tension hz
Gastrointestinal_ bleeding ventricular_assist devices cardiac_ nurse
lVAS implantation

cPCs functional_ capacity VO2
Cardiac_ hypertrophy énergétique
eAST rhythm_control_therapy cardiovascular complications AF
Frailité heart_ failure aging
Nicorandil doxorubicin
HF
Heart_t2 heart_ failure
Framingham_ Heart_ Study hf
ED intubations congestive_ heart_ failure
diuretics congestive_ symptoms heart_ failureHF
aCP
bottleneck stent chronic_Myocardial_ischemia heart_ failure pigs
mortality iCD-HF
inpatient records HF
aRIC HF
cardiovascular
pneumonia conditions
therapy

paediatric cardiac transplants
AF-free_ probability catheter ablation sinus rhythm
NOc
implantation cRT
HRQoL hgb
degs osprey networks
iron
ED CHF
deficitSD
Medicare post-acute_care_ transfer
QRs
clinical change
vegetables nuts grain_ intake mortality
benefit

QT_ intervals SDQT
ventricular_contractile_ reserve pulmonary hypertension
Heart_de_aortic_ blood_ flow doxorubicin
acute_ autonomic_ nervous_system_ modulation QTVHF
cardiovascular_ deathHF btes
cardiac_resynchronization_therapy dialysis-dependent patients heart_ failure
RVPO BiVP co rs synchrony CS
ventricular-arterial coupling SV
Myocardial_pde2 expression HF
mapping myocardial_ fibrosis
BAT sympathetic_ outflow parasympathetic_ activity
resistin acute anthracycline_induce_ cardiotoxicity
skeletal_ muscle_ mass VO2
double-blind active
cardiac_ catheterization extubated
atrial_ fibrillation pacemaker
pump_changes pump thrombosis hemolysis
World_ Health Organization HF
myocardial_ tissue pKA
body_ Mass index cRF treadmill
implantions
diastolic_ failure cardiomyopathic restriction
autonomic_ nervous_system_ activity QTV
psychosocial factors heart_ failureHF
hospitalisations readmissions mortality
heart_ failure high-density_ lipoprotein
ed visits CHF intubation
Frailité elderly

Medicare fee-for-service
physician_continuity conditions hospital_discharge
SD

bisoprolol mortality
PSs social_support btes
ethics_ Rounds
high-risk
cardiac_ stress β-AR


heart_ rate ivabradine ventricle heart_ failure
echocardiographic remodeling cardiac_resynchronization
biomarkers neurohormonal stimulation inflammation endothelial dysfunction
heart_ failure Canadian_ Cardiovascular_ Society
Neurohormonal abnormalités pathophysiology congestive_ heart_ failure chf
Heart_ Failure Pathophysiology Medical Treatment
parasympathetic_ neurotransmission acetylcholinesterase
end-stage_ renal disease outpatients systolique_ heart_ failure
anemia heart_ disease College_de_physiques
renal DNx cardiac_ autonomic balance CHF sympathetic_ tone
ventricle RV cardiac
radiological signs HF
congestive_ heart_ failure chf
mri scanner heart
Jehovah_s Witness sickle_cell_ disease anemia
chromatin_subproteome mouse_ heart
Mediterranean DASh mortality women heart_ failure Womens_ Health Initiative
l-type_ca2_ currents Rad congestive_ heart_ failure
cardiopulmonary_ exercise heart_ failure
morbidity mortality HF
coût heart_ failureHF
muscle-wasting_ syndrome acquired_ heart_ failure Fontan
miRNAs heart_ failure
Health Buddy_program content-driven_ telehealth_system care management
anthracycline-treated breast cancer cardiotoxicity
dobutamine furosemide oxygen
therapeutic
Mortality aCS consultation
cPCs diabetes
LVEF long-term_ mortality
Health Buddy_ Program ED hospital
inhospital mortality bNP mortality
ctnt NT-probNP HF
RV_ dysfunction weight_ loss fat
futility
MT consultation abdominal
complication
mortality
fréquence
ejection_fraction cardiac_resynchronization_therapy heart_ failure
biventricular_pacing_ on_ left_ heart_ twist porcine_model_de_ right_ heart_ failure
Stress doppler echocardiography pulmonary hypertension
aortic valve ventricular implantation
ventricular ejection_fréquection_fréquence heart_ failure precapillary_ pulmonary hypertension
myocardial_ diastolic_ dysfunctionDD collagen_deposition
septal_ wall avd free wall_ CS VVD
RV ventricular_ dysfunction
pulmonary artery
cs regression
LV strain echocardiography ablation
HR_reduction beta_blockers hff

cPCs functional_ capacity heart_ failureHF
implantation circulatory_assist device
i-mg_ myocardial
circulation_progenitor_cells heart_ failure
systolic diastolic_metral leaflet
inhibition protein_ kinase soluble_ guanylate_ cyclase contractile
beta_blockers heart_ failure
PD refractory end-stage_congestive_ heart_ failureCHf
perioperative
trastuzumab cardiac
économique af heart_ failure Québec
multivariable_hierarchical_regression
st2
cardiac_ Mena deletion cardiac_ dysfunction hypertrophy
bundle-branch_blockLBBBLBBB
CHF atrial_ explants c-Kit_cells sham explants
HF valve plasty MS mva
NYHA
pressure_ ulcers surgical
Timed_up_go
Nursing-sensitive_ outcome_change_ scores hospitalized_ older adults heart_ failure
chelation heart_ iron
transcatheter
black_race mortality
social_support
Human resistin chemotherapy-induced heart_ failure
therapeutic fluid_Overload
hospitalized_ older_ adultsHF

echocardiographic invasive_hemodynamic
right_ atrium_ mass prolapse tricuspid valve stenotic_ physiology
apoptosis pacing-induce_ dilated_ cardiomyopathy
ventricular implantation
cardiac_ catheterization thrombotic_ obstruction right_ coronary artery
Western blots monoclonal_antibodies Ser83 phosphorylationHF
Fontan_fréquence ventricular liver
mt
Chinese_ herbal medicine dilated_ cardiomyopathy heart_ failure
chronic_ heart_ failure chf sympathetic_ tone autonomic_ imbalance
implantable implantable cardioverter-de_fibrillator_de_activation
electromechanical_delay dyssynchronous_ heart_ failure
EH cardiac_ filling_tensions
hfff dietary_sodium ventricular
Heart_ failure mortality
proteins Western blot DNA_ fragmentation tunel autopsy
magnetically_ Levitated_left_ventricular_ Assist HF
neurological cardiovascular
heart_ failure
hf
MADit-cRT
chemical instability cogeneration_de_ nitrite vascular
Czech Republic
BETs mouse TAC hf
dopamine nesiritide
ue-va-RT
transfusion mortality
consultations
cardiac nurses
closure
coût-effective
California office_de_ State_wide_ Health_planning_de_ Development Patient_discharge
extracorporeal membrane_ oxygenation infarction_related refractory_ right heart_ failure
anticoagulation therapy heart
temps-varying Seattle Heart_ Failure
Paco2 cerebral_ blood_ flow carotid bodies
pathophysiology HF medical management
ed physicians suburban_hospitals New Jersey New York
heart_ failure protein_ kinase
cox_regression cardiovascular events psoriasis
énergie_ metabolism heart hypertrophied_ heart
echocardiography shunt implantation
inotropic effect beta_blockers heart_ failure
mechanical_ cardiac_ support renal
ECmo VAD
functional MS LV dilatation functional MS
NT-probNP circulation HF
mortality morbidity cancers budget
NT-probNP
HDl-induced production flow-mediated_dilatation ET
therapeutic
aHF
PAD ankle-brachial index
cp
HR ivabradineTAC
TM sts
HRQoL
Reasons_nontreatment
computing_ readmissions hospital pay-for-performance
iCD
HF

ventricular_assist device extracorporeal_ membrane oxygenation pediatric heart_ failure
Cardiorespiratory_ fitness body_ mass_ index heart_ failure
cox
New York_ Heart_association
Exercise_ intolerance heart_ failure
pro-adrenomedullinMR-proADmfm
vasopressin_ receptor_ antagonist tolvaptan Japanese_heart_ failure
functional MS ring_ annuloplasty ischemic MR LV
bNP NT-probNP biomarkers heart_ failure
psoriasis smoked diastolic_ blood_tension body
interleukin_ receptor ST2 beta-blocker_therapy heart_ failure
HF cardiac_murmurs blood_tension hg
biventricular_ dysfunction HeartMate
renal_ dysfunction mechanical_ cardiac
ventricular_assist devices device therapies
Functional MS
ventricular_dilatation dysfunction
anemia heart_ disease
heart_ failure systolique_ heart_ failure
HF VT beat-to-beat QT
cXL-1020 myocytes hearts
implanted
PB PB HF
tug tests COPd CHF cRF
Heart_ failureHF
rhythm-control rate-control
HF health service_ provision HF
hemoglobin
heart_ failureHF

CF lVAD AI heart_ failure
cfa
hemodynamically_ unstable cPR
social mandate
cardiovascular_risks diabetes mellitus hypertension hyperlipidaemia

long-terme
sudden_ cardiac death
hospital_ mortality
administration trastuzumab CHF
rehospitalization
hospitals
biomarker-guided_ clinical
medical records
Circulation_pro-b-type_natriure_peptides heart_ failure
heart_ failureHF ventricular_ ejection_fractionHFpEF
Pyridostigmine myocyte collagen_density ventricle
cardiac_ angiogenesis coronary_perfusion cardiac_ fibrosis
implantable_ cardiac_de_fibrillator
adenylyl_ cyclase g-protein_ coupling
implantation heart_ failure ventricular_tachycardia
signaling_pathways pressure-overload-induce heart_ failure
Exercise_ intolerance hff
systolic HF unclear_ etiology coronary_ angiography
Heart_ failureHF sympathetic_ activity parasympathetic_control heart
ATP demand XO-mediated ROS mitochondrial_ respiration contractile
implantation ventricular_assist device
atrial_fbrillation congestive heart_ failure rhythm-control rate-control
ejection_fraction ef collateral_ growth myocardial_perfusion
HR tNF nbDMARD
surgical_revascularization catheter-based revascularization
Morpholino-based knockdown nucleolin protein expression
bNP PAD bNP HF
CVd psoriasis
Rotterdam psoriasis cardiovascular outcomes
race HF
HFpEF
parasympathetic_fonctionnel HF
diabetes mellitus cardiovascular disease
clinical_ prediction_ rule CAD cause_de_ systolic_HF
cognitive impairment mortality
SCHf
ECmo egFR egFR
haemodynamic pulmonary
prediction_ rule
CAD
HF-related cachexia RV
acute_HF
hgb kccq
hospital cardiac_specialty_hospital
aCS techniques MT VAD
sonographic histological functional_ abnormalités gastrointestinal
energie_ substrate_ metabolism
jugular_venous_tension peripheral_ oedema volume
Spironolactone hyperkalemia kidney injury
heart implantationsLV implantations heart_ failure
functional_metral_ stenosis ring_ annuloplasty ischemic_ mitral_regurgitation
doagulants antiplatelet drugs heart_ failure atrial_fbrillation
mechanical_ cardiac_ support renal_fonctionnement end-stage_heart_ failure
natriuretic_peptide biomarkers point_de_care
Heart_ failureHF
EH hz renal impairment hypertension
pump-exchange technique redo sternotomy cardiopulmonary_ bypass
chronic_Myocardial_ischemia heart_ failure
mouse HF transition compensated LV_ hypertrophy HF hHD
MS HF functional MS
sympathetic parasympathetic HF
HF HF ms mva
heart_ failure ejection_fraction doppler_ echocardiography

cardiovascular conditions hf
health_ insurance health_system_de_capitaux Food_de_ Drug Administration
hereditary_congenital_ abnormalités heart nontraumatic_ death
Raf-MEK_1/2-erk1/2 signalling remodelling
albumin lVAD
HeartMate_ II lVAD
bisphosphonate heart_ failure
sustainability commissioning hospital-based
HF-induce remodeling EMd prolongation
early-onset MI HF
coût
maladaptive_ molecular
patient_ safety
Xanthine_ oxidase ventricular_synchron diastolic cardiac
ventricular_ longitudinal_synchrone_stationnaires atrial_frébrillation
Heart_ failure medicine atheromatous_ coronary disease
medications heart_ failure NCDR_ PINNACLE
unloading_de_the_heart HR systolique_ heart_ failure
HFpEF
hpf breathlessness fatigue fluid_retention
circulation_mediator_de_ insulin_ resistance monocytes inflammatory stimuli
NT-probNP
aortic_ valve surgery new-onset lVAD
Nordic_ walking cardiac rehabilitation
spironolactone systolique_ heart_ failure
réseau Cytoscape functional_enrichment DAVID
blacks hypertension diabetes ischemic_ etiology socioeconomic status
immunodetection NT-probNP antibodies
Fontan_ circulation sVR cardiac index pediatric
mineralocorticoid receptor_ antagonists
rehospitalization medicare fee-for-service
palliative
HF crtehazard
lVAD biventricular
oxidative stress GTPase_ Rac1 hearts ANS_mice
Fontan_ circulation skeletal_ muscle_ mass metabolic
vent_ circulation right_ heart_ failure
Heart_ failure HF Latin AmericaLA HF
PD complications therapy hf
transformed

heart_ failureHF Heart_ Failure_adherenceHARt
β-Adrenergic_ receptor_blockade heart_ failureHF
Myocardial_ infarction left_ anterior descending coronary artery occlusion
ventricle_overload stroke ventricular_ ejection_ time lVET
nonselective beta-blockers cardiac_synchrone_ activity hemostasis heart_ failure
cardiovascular death urgent_ cardiac transplant
Chromatin-associated proteins chromatin_ structure DNA
hfff
β-Blockade cardiac_ angiogenesis heart_ failure VEGF
NT-probNP HF immunoprecipitation
parasympathetic tone pyridostigmine ventricular_ dysfunction heart_ failure
myocardial_ischemic events cardiac_resynchronization
HFHF ejection_fractionHFpEF hypertension
NYha_fonctionnel_ class quality-of-life
dégs non-ischemic ischemic heart_ failure
RV_ dysfunction weight_ loss body_ composition hz
heart_ failure Emergency_ Department ed ed
gut inflammation heart_ failure
CHF emergency_ departmentED intubated
robot-assisted_ gait_therapy Lokomat_system heart_ failure


lVET ICU

Intravenous iron heart_ failure iron_deficiency
pp acr CMS
mortality LCx LAD two-vessel disease
stress conditions maladaptive remodelling heart_ failure
psoriasisUV
congestive_ heart_ failure
Beta-blocker
pulmonary_hytensionPH heart_ failure
White rabbits renal DNx pacing-induced CHF
mutant_mice_ overexpressing Hand heart_ muscles pathological_ hypertrophy
dialysis echocardiographic
heart_ failure ejectionfraction
QT_ variability QTV QTV cardiac_ death
mitochondrial structure sarcome_microstructure
consenting ambulatory HF ventricular ejectionfraction
ET HDL_fonctionnement CHF-NYha-IIIb HDL_fonctionnement
aim implantable_ cardioverter-de_frébrillator_deactivation
microRNAsmiRNAs heart_ failure
implantation heart_ rate renal fonction spironolactone
CHF therapeutic_ interruption neurohormonal
physician_ follow-up_ after_discharge
catheter ablation antiarrhythmic drugs rhythm_control therapy
poc technologie
cardiac_ dysfunction subcellular_ alterations metoprolol heart_ failure myocardial_ infarction
Cardiac_ magnetic_ resonance_ postcontrast heart_ failure ejection_fraction
LV diastolic_ dysfunction filling_tensions doppler_ echocardiography
heart_ magnetic_ resonance_ imaging chelation_ choices heart_ disease thalassaemia
Myocardial collagen collagen_ cross-linking titin phosphorylation
mri tidal_ respiration myocardial swine heart_ failure
RAS-blocker hff HFpEF
Systems_protecomics cardiac_ chromatin nucleolin regulator_de_ growth cardiomyocytes
Cardiac_ failure diabetes heart_ failure
zf1 rats heart_ failure ejection_fraction
Hemoglobin HF-action
passage_fréquence_fréquence_fréquence_fréquence heart_ failure cardiology
arterial_ tonometry lVET precapillary_ PH heart_ failure
transoesophageal_ echocardiography shunts thrombosis migration
Cross-talk heart adipose_ tissue cachectic_ heart_ failure

cardiovascular_ disease
PRIncipal_ FINDINGs HF conditions
eseptal
psoriasis cardiovascular diseaseCVd
aCS problems oHT transplant MT VAD
beta-blocker
coût
Hospital AMI mortality
proteins
Plasma HF
index_admission
HF
Rhythm_control_therapy
therapy
cardiovascular disease dRS
heart_ failure CLCNKA_sNP
miRNAs cardiac remodeling heart_ failure
sandwich AlphaLISa immunoassays NT-probNP
hf rheumatoid_arthritisra
transduction_pathways signalling proteins
clinical_diastolique_ dysfunction cause_ mortality
regulation_de_ feeding nutritional anti-inflammatory effects CHF
pde2-overexpressing cardiomyocytes norepinephrine hypertrophic
alendronate dose-dependent_reduction
frailty risk heart_ failureHF
Bax bcl-2 proteins
RAS- β-blocker
GDMT GDMT BAT
heart_ failure bisphosphonates
hz
β-Blocker-induce cardiac_ angiogenesis therapy cardiac remodeling
nicorandil cytotoxic doxorubicin Ehrlich_carcinoma
c-statistics biological_ phenotype deficit
Myxomas cardiac_ benign tumors left atrium
natriuretic_peptides
LV_ diastolic_ dysfunction hff
Renal_denervation dx CHF
implantable cardioverter-de_fibrillator_de_activation
FontanSAF catheterization
heart_ failure ventricularLV ejection_fraction
ambulatory iCD mortality multivariable_regression
sinus rhythm antiplatelet agents anticoagulants
physician_ follow-up_ after_discharge physician_continuity heart_ failure
MT VAD aCS mortality morbidity
cardiotoxicity doxorubicin anti-neoplastic cancers
fes preserved_ ejection_fractionHFpEF
lifesaving drugsHF ejection_fraction hrEF
refractory_congestive_heart_ failure peritoneal_dialysis
ICU_admission precapillary_ PH heart_ failure
Myocardial_ loss iRS1 iRS2 heart_ failure MAPK insulin_ resistance
ARNI inhibitorsangiotensin-receptor_ neprilysin
Functional_metral_ stenosisMS ring_ annuloplasty ischemic_metral_regurgitationMR
heart_ failure ejection_fraction hff
Heart_ failure ejection_fraction hff cardiovascular_ reserve
lean ZSF1 obese ZSF1 diabetic
Mammalian_ enabled mena cytoskeletal_actin_ dynamics heart_ failureHF
Gastrointestinal_ bleeding ventricular_assist devices
heart_fréquence ventricular_ ejection_fraction
myocardial pde2 intracellular antiadrenergic therapeutic HF
bNP NT-probNP coronary_ artery diseaseCAD
heart_ failure left_atrial_tension hospital
hyperkalemia kidney injury spironolactone
Heart_ failure ejection_fractionHFpEF cardiovascular_ morbidity mortality
eCG cRT
NT-probNP
transfusions heart_ disease
benefits spironolactone
VO2 joint_ effect
HF
sst2 low-dose b cardiovascular event
breast cancer patients trastuzumb-related CHF
PVf PB BP


aerobic_ capacity left-hand_ grip_ strength body_weight waist_ circumference anxiety
Process_redesign
doppler_ imaging left ventricular_ filling_tension systolique_ heart_ failure
heart_ failure hypertensive_ heart_ disease angiotensin_ II infusion nephrectomy salt
Kansas City Cardiomyopathy_ Questionnaire heart_ failure ejection_fraction
anemic iron-deficient
heart_ failure
trastuzumab CHF nontrastuzumab
HR beta-blocker therapy
coronary occlusion collateral_ growth stent occlusion
psoriasis patients atherosclerosis cardiovascular events psoriasis
carotid_ intima-media_ thickness psoriasis
pde2 failing hearts β-AR
Mechanical_synchrony QRs cRT
Remote_ monitoringRM heart_ failure
i heart_ failure hcrte-d
RV dysfunction cardiac_ cachexia
egf diuretics hypertension ESRD
chronic_heart_ failure Hungary
pharmacologic
point-of-cares NP ed outpatients acute_heart_ failure
Renal_ dysfunction mortality cardiovascular events caBG
arterial_ complianceTAC end-systolic_ elastance ees
Renal_ dysfunction myocardial_ infarction coronary_ artery_ bypass graftcaBG
cardiovascular_risk factors diabetes mellitus atrial_fbrillation coronary_ artery_ disease HFpEF
coronary_ artery disease systolic_ heart_ failure
anthracycline congestive_heart_ failure haematopoietique_cell transplantation
biventricular_ support HeartMate_ II lVAD CentriMag_rVAD mortality hospital_discharge
e-cfus mortalityhazard
heart_ failure ejection_fraction myocardial_ infarction
isoprenaline_ infusion SDQT hNorm HF
angiogenesis post-myocardial_ infarction heart_ failure
aldosterone_ antagonist heart_ failure
acute_ heart_ failure hf
surgery HF hypertension vasodilators diuretics
HF remodeling EMd dyssynchronous_ failing_ heart
Shunt implants transseptal catheterisation transoesophageal echocardiographic
dopamine nesiritide
hff
MEDline EMBAse cochrane_ databases clinical_ trial
egf VAD ECmo
black_race HF cardiovascular mortality
biomedical reasons
Clinician
HF
Care_management content-driven_ telehealth technologies high-cost Medicare beneficiaries
lVAS
ERC epicatechin
Ea TAC HR ees ivabradine
physician adherence HF_cPGs
HF hf mortality
HDl_fonctionnement CHF ET HDL-mediated_ vascular
Pyridostigmine vascular_endothelial_ growth_factor_ protein left ventricle myocardial_ angiogenesis
idiopathic_ dilated_ cardiomyopathy
proteomics chromatin-associated_ proteins detergent
tNF antagonists HF nbDMARDs RA
pharmacologic management acute HF
HeartMate_ II implantation
RV_ dysfunction body_ mass_ index figure cachexia
atrial_fbrillation carvedilol metoprolol
cf HF mortality_risk HF
CHF Diseases codes
cardiac_ disease heart_ failure
cXL-1020 hno inactive cXL-1051
myocardium_ displays pKA
cardiac_ growth plasticity disease chromatin_ remodeling
elastic_n2Bus_ segment PEVK
Robot-assisted_ gait_therapy Lokomat_system heart_ failure
Nicorandil mitochondrial_ dysfunction doxorubicin-induce heart_ failure cardioprotection
RAS hypertension nephropathy congestive_ heart_ failure
natriuretic_peptide bNP creatinine natremia
heart_ failure mechanical_support devices Cardiology-cardiovascular_surgery_conensus_ Report Heart_ failure
Heart_reduction exercise heart_ failure ejection_fraction beta-blocker
SDQT SD RR grt QTV heart rate_variable
Self-Care_of_ Heart_ Failure SCHf psychometric profile
Isoelectric_ focusing RIα ser77 ser83 phosphorylation
functional MS valve plasty degenerative MR LV
management_de_ end_heart_ failure Heart_ failure public_ health
st-segment-elevation MIs Killip conditions
myocardial_ infarction m heart_ failureHF
arterial_ elastance pulsatile_ afterload heart pressure
NT-probNP MR-proANp MR-proADm
implantable_ cardioverter-de_fibrillator
HeartMate left_ventricular_assist_system lVAS heart_ failure
hf PAf biosynthetic enzymes lyso-paf-AT
sst2/low-dose BB sst2/high-dose BB
HF complicating AMI mortality
zebrafish nucleolin genomic_reprogramming
cardiac events
LV ejection_fraction PCWP hg
CHF ed visits CHF patients intubated
grs h CV
egf VAD ECmo+VAD renal
Physician_ volume hf noncardiologist physicians
ejection_fraction
risk-adjusted mortality


physician adherence
mADIt-cRT multicenter_automatic_deibrillator implantation Cardiac_resynchronization_ Therapy
cardiac_ magnetic_ resonance_ imaging invasive_hemodynamic assessments
Morbidity mortality HFpEF HF ef
Logistic_regression
intravenous_ iron
emergency department acute_heart_ failure
molecular biomarkers pathophysiology chronic HF
BET_bromodomain-containing_ proteinBRd4 cardiac
hospital_ stay congestive_ heart_ failure
aUCs eseptal eemeanseptal QRs resynchronization
heart_ failureHF inpatient
diuretics HF
IVc occlusion co correlated twist apical rotation RS synchrony CS
carvedilol metoprolol heart_ failure devices
devices gastrointestinal_ bleeding
readmission_ rate patients_with_ heart_ failure
public_ health air pollution
Medicare inpatient HF acute_care hospitals
t1-mapping_sequence tidal_ respiration gadolinium-chelate_ contrast
HFheart_ failure t2d diabetes Skm muscle
catheter ablation atrial_ fibrillation heart_ failure ejection_fraction
dopamine nesiritide acute_ heart_ failure renal dysfunction ROse acute_ heart_ failure
cardiopulmonary_ exercise muscular_ strength peak_ quadriceps_force
DAPcdystrophin-associated protein_ complex sarcomeric_microstructure
HF rats pyridostigmine basal_ heart_ rate vagal sympathetic_control_de_ heart
eCG ion_ channelopathies cardiomyopathy
RAS neprilysin_ inhibition chronic heart_ failure systolic_ dysfunction
mouse HF hh hd salt_ loading uninephrectomy ANG_ II infusion
Benefits HF ejection_fraction pEF
in-trial costs Québec Health Insurance Board disease-specific costs Ontario Case_ Costing
idiopathic_ dilated_ cardiomyopathy tuscany
Erythropoiesis-stimulating agents anemia heart
mitral_ valve plasty degenerative_ mitral_regurgitation
Myocardial titin hypophosphorylation heart_ failure ejection_fraction rat metabolic
HFpEF kccq
HF MI preserved ejection_fractionEF
PD diuretic edema functional
serum_ creatinine serum_ potassium
RV ventricular dysfunction
Mortality inpatient_admissions hospital_ days emergency department_de_ED
Chronic_heart_ failure transforming growth_factor_ beta-dependent_ yield atrial explant-derived c-Kit
anemia chronic_ heart_ failureHF
HeartMate_ II lVAD CentriMag_rVAD
readmission
echocardiographic score cRT
économique models lVAD
ejection_fraction
AF ablation
Cardiac insulin-resistance mitochondrial_énergie heart_ failure pressure-overload hypertrophy
If-channel_ inhibition hemodynamic tolerance heart_ failure ejection_fraction
heart_ failure nurses cardiology services mortality
PAf metabolic_ enzymes heart_ failure
Phosphodiesterase-2 failing hearts blunts beta-adrenergic cardiomyocytes
trastuzumab cardiotoxicity congestive_ heart_ failure chf
myosin_binding_ protein-c phosphorylation ser23/24 troponin_ I phosphorylationHF
renal dysfunction stroke myocardial_ infarction heart_ failure CABG
pyridostigmine methylatropine propranolol cardiac
echocardiographic_ predictors cardiac_resynchronization_therapy cRT
chromatin_subproteomes heart_ failure
NT-probNP antibodies nonglycosylated
Hum-retn mice cardiac mRNA inflammatory cell_adhesion Retn
nbDMARD tNF
end-stage_heart_ failure pediatric mechanical_ cardiac
hff hf hf hf HR beta-blocker therapy

cox hazard models temps ESRD death ESRD

rheumatic MS mva
pigs inferior vena_cava ic co
doxorubicin ip serum_ resistin Hum-retn_mice
nutritional_ abnormalities CHF fat carbohydrates proteins
costs high-volume physicians
deactivation
University_of_connecticut Heart_ Failure Center cardiologist heart_ failure
aldosterone_ receptor_ antagonists morbidity mortality systolic_ heart_ failure
XO inhibition cardiomyocyte_ bioenergetics LV aCF rat
ecardiographic measures N-terminal_pro-brain natriuretic_peptide inflammatory markers
hf HF pyridostigmine stroke ejection_fraction cardiac_ output contractility ventricle
carvedilol thromboembolic events heart_ failure β2-receptor_haplotype
uPR protein kinase ER kinaseperk calreticulin CHOp HF
heart_ failureHF cardiopulmonary_ exercise anaerobic_ threshold
randomised-controlled trialsRCts
therapeutic biomarkers molecular_ dysfunction HF
CV_ deaths non-fatal_ stroke heart_ failure
sensitivity CAD
HF
sCN5a transcript uPR downregulation cardiac_ genes HF
eAST rhythm_control therapy AF cardiovascular complications AF
air pollution cardiovascular_ health acute_méocardial_ infarction
économique_ climate NHs behavioural-change chronic_ disease
middle-aged_ recreational_ athletes sudden_ cardiac deaths atherosclerotic CAD
dialysis-dependent patients HF cRT implantation
Peak_ oxygen_ consumption oxygen_ pulse
RV pathophysiologic mécanismes RV
hct_fréquence hct City_of_ Hope
Women_s_ Health Initiative HF
VAD ECmo+VAD ECmo
albumin inflammation hepatic implantation
ventricular RV left ventricular_assist device lVAD
neurohumoral blockers HF co-morbidity_ burden
st2 reclassification_de_risk c statistic discrimination
AMI heart_ failure kidney infection UTI
cox proportional_ hazards
Testosterone_therapy exercise_ rehabilitation heart_ failure testosterone
oddshazard HFAMI discharge
pasp
kccq Kaplan-meier curves
mAIN_ oUTCOME_measuRES grLS index_ beat CV cox proportional_ hazards
Lipolysis énergie_ expenditure natriuretic_peptidesNPs CC
biomarkers heart_ failure
CHF infarcted animals left ventricle_ end-diastolic_tension hg scar
Olmsted County Minnesota MI HF
hearts Mena cardiac_ injury Mena HF
RAS doppler_ ultrasonography tomographic_angiography magnetic resonance_angiography
lVAD transplantation_éligibility

cRT-d IE defibrillator-only therapy
IC multicenter_automatic_deibrillator implantation Trial-Cardiac_resynchronization Therapy
Health Buddy_program chronic_ obstructive_ pulmonary disease congestive_ heart_ failure
Cardiopulmonary echocardiographic myocardial ventricular filling
echocardiography ste biVP ventricular_tensionRVPO
hypoalbuminemia postoperative mortality left ventricular_assist device lVAD implantation
inhibition vascular_endothelial_ growth_factorveGF transition compensatory_ hypertrophy cardiac_ failure
ventricular ejection_fraction heart_ Failure ISrael
obesity diabetes mellitus metabolic_risk_ factors heart_ failure ejection_fraction
nicorandil cardioprotection apoptotic signaling pathway DNA fragmentation mitochondrial_ ultrastructural changes
percutaneous_ coronary_revascularization hemodynamically
atrial_ fibrillation atrial_tachyarrhythmias ATP shock therapy
pathophysiologic mechanism renal_ underperfusion renin- angiotensin-aldosterone
proteomics pressure-overload-induce heart_ failure mitochondrial-targeted_peptides
HR
av_mice LV_fractional_shortening lung_weight
functional_enrichment_analyse programmed_cell_ death DEGs
dysfunction rad_variant q66p congestive_ heart_ failure
PERK inhibition sCN5a kv mRNA splice
heart_ failure spironolactone hospitalization
eCG atherosclerotic CAD sudden_ cardiac death
HR dynamics temps-domain HR variability risk
sex EF bNP HF bNP sex ef
HF index AMI mortality
BETs transcriptional_ pause_release transcription
apoptosis heart_ failure
diuretic_ efficacy neurohormonal_activation fluid_Overload
uPR channel_mRNA splice cardiac na+ current hz
LVEF
Mena expression HF cardiac_ pathophysiology
NP POc NPs clinical_care_ delivery
RECENT FINDINGs intestinal morphologie permeability absorption_fréquence
benefits
fibrosis heart_ failure myocardial_ tissue left ventricular_ tissue trichrome_ blue
pulmonary arterial_synchrone_tension heart_ failure ventricular_contractile
atrial_fréquence atrial_ fibrillation Stroke
Kansas City_cardiomyopathy kccq HF ef HFpEF
Trastuzumab CHF nontrastuzumab
Blood_tension arm_ cuff stroke ejection_fraction end-diastolique echocardiography
atrial_ fibrillationAF heart_ failureHF stroke anticoagulation
salt_ loading uninephrectomy ANG_ II infusion cardiac_fonctionnement miceHF
bottleneck stent myocardial_ infarction antiplatelet
LVEF mortality acute_decompensated_HF
echocardiographic score LV reverse_ remodeling
Fontan_ failure circulatory_derangement hemodynamic portal_ hypertension cardiac
biventricular support HeartMate_ II lVAD CentriMag ventricular_assist devicerVAD
HF-action hgb HRQoL kccq
functional MS valve plasty annular_size_reduction degenerative MR LV

pathological remodelling heart cardiac hypertrophy HF fibrosis inflammation
idiopathic_ dilated_ cardiomyopathy
functional MS valve plasty degenerative MR LV disease
Frailty heart_ failureHF biological_ phenotype
high-volume physicians
e-cFUs CD34_vegf

ARNI cardiovascular mortality hospitalization heart_ failure
ventricularRV
myocardial DD muscle_ strip_ stiffness titin hypophosphorylation
cardiac_ hypertrophy nucleolin
HF
anaerobic metabolism respiratory

virtual cohorts coût-effectiveness
cardiac_ magnetic_ resonance amyloidotic_ pattern multiple myeloma osteomedullary biopsy
DASh ventricular-arterial coupling hypertensive heart_ failure ejection_fraction
Vascular_endothelial_ growth_factor_blockade beta-blocker therapy cardiac angiogenesis remodeling heart_ failure
implantable implantable_ cardioverter-defibrillateurs ids cardiac_resynchronization_therapy cRT mortality
HFpEF echo-Doppler_cardiography invasive haemodynamic assessment
RAS- β-blocker hff hfpf hospital_admission
ventricular_assist deviceVAD extracorporeal_ membrane_ oxygenation emo renal
American College_de_ Cardiology_American_ Heart association RAS
LV remodeling diastolic properties XO
contractile_fonctionnement LV dilatation LV end-diastolic_tensionwall_ stress lung_weight
Circulation_progenitor cells cPCs endothelial_ repair cardiovascular
implantable implantable_ cardioverter-de_fibrillator_de_activation heart_ failure
NT-probNP plasma dyspnea left ventricular_ dysfunction ED
Caucasian sNP rs10927887 Ka renal_ chloride_ channel_général cCNKA
Physician_ volume medically_ managed diseases HF
frail
LBBB implantable implantable_ cardioverter_de_fibrillator-cRT
RM discharged heart_ failure
exercise-induced PASp hg PASp
eplerenone HF-ref hyperkalemia WRF
t1-mapping technique diffuse_ myocardial changes heart_ failure contrast agent breath-holding
bt DT coût-effectiveness bt
hff
expenditure health_per capita gross_national_ income HF
af pharmaceuticals hfff
is cRT-d heart_ failure
SDQT HFVT hnorm fixed-rate_atrial_pacing
bNP inhospital_ mortality
blood_tension lipid-lowering therapy smoking RAS
QRs morphologie cardiac_resynchronization_therapy cRT
mitochondrial_ complex_V activity aac phosphocreatine ATP
Yorkshire swine implanted pacemakers ventricularly paced heart_ failure
implantable_ cardioverter_de_fibrillateursICds
Cardiovascular Outcomes Renal_ Atherosclerotic_ LesionscoRAL stenting RAS
MI metoprolol plasma norepinephrine dopamine epinephrine
st2 cardioprotective_ signaling myocardium biomarker heart_ failureHF
skeletal_synchrone_ structure heart_ failure diabetes epicatechin-rich cocoa
embryonic_ gene programs pathological_ heart disease
heart_ rateHR ivabradine systolic_ heart_ failure
mdc
acute_heart_ failure aHF
multiparametric echocardiographic score reverse remodeling cRT
biomedical treatment CHm biomedical treatment dCM heart_ failure
centrifugal_fréquence_pump hemocompatibility magnetically levitated rotor blood-flow
sst2/low-dose b sst2/high-dose cardiovascular events
Mediterranean Dietary_Approaches_ to_ Stop_ HypertensionDASh mortality postmenopausal womenHF
POc NP

echocardiography cardiac_ diameters b-treated
LBBB implantable cardioverter_de_fibrillator-cRT
mortality readmissions costs physician hospital
MEDline EMBAse PsycINFO

therapeutic left-to-right interatrial_ shunting heart_ failure ejection_fraction
systolic HF cXL_-1020 left_ right heart_ filling_tensions systèmeic_ vascular_ resistance cardiac stroke
heart_ failure hypertension mitral_regurgitation mitral stenosis
PERK_activation sCN5a kv4.3 mRNAs transient_ receptor mdp mRNA
implantable_ cardioverter-de_frébrillator Heart_ Function Clinic University_ Health_ NetworkToronto
cardiovascular_ death stroke heart_ failure myocardial_ infarction
Exercise-induced PASp pulmonary hypertension ventricular_contractile
renin-angiotensin-aldosterone sympathetic_organs CHF
Cardiac-resynchronization_therapy cRT mortality chronic_ systolic_ heart_ failure QRs
truncated na+ channels unfolded_ protein response uPR sCN5a electric remodeling HF
Right_ Heart_ Foundation defects right_ Heart_ failure
changes myofiber dynamics myofiber_ shortening emd dyssynchronous HF
ankle-brachial index pulse-wave_ velocity coronary artery calcium scores
allopurinol LV contractile_fréquence ROS myofilament
antiplatelet agents anticoagulants vascular diseases
cardiac_ hypertrophy pressure-overload abdominal aortic_constriction aac
HF HF epidemiologie SH cd rheumatic fever
medications heart_ failure ejection_fraction
caloric restriction aerobic exercise_training_exercise QOL hff
chronic_ heart_ failureHF hemodynamic_ disorder syndrome dysfunction
HFpf diastolic filling temps heart_ rate
hgb kccq hgb HRQoL
heart_ failure hospital_discharge readmissions
mice cardiac_Myocyte_specific Mena_overexpression tgtetMena cardiac_pathologie
Fontan_ failure hemodynamically heart_ failure systèmeic_ vascular_ resistance sVR cardiac
implant

metabolic_ exercise cardiac kidney index
heart_ failure refill_ compliance etidronate alendronate
physicians advanced_ heart_ failure
therapeutic AF heart_ failure financière
therapy
ET HDL-mediated_protective_ effects molecular pathways chronic_ heart_ failureCHf
rehospitalization Medicare hospital_ claims Medicare post-acute_care_transfer_policy
men cRF HF mortality
figureffffcc
intermacs interagency_ Registry Mechanically_ Assisted_ Circulatory_ Support
eccentric ventricular hypertrophy heart_ failure ejection_fraction
ventricular ejection_fraction heart_ failure preserved_ ejection_fractionHFpEF
ventricular_ ejection_fraction left ventricular_ diastolic_ end_ diameter
β-adrenergic receptor_blocker therapy myocardial_perfusion neoangiogenesis failing_heart
extracellular_ matrix left ventricular biopsies tissueFAXs technologie
hART hf hf hf hf hrf
tachypacing-induced HF cXL contractility end-systolic elastance venoarterial dilation
actin_ cytoskeleton mitochondrial metabolism glycolysis_gluconeogenesis citrate
resistin anthracycline-induced_ cardiotoxicity heart_ failure
bone_ morphogenetic protein rRNA transcription heterochromatic chromatin
ventricular_assist devices lVADs heart_ failure pump
scc5a angII hypoxia uPR downregulation
fréquence HF mortality hazard
HF hyperkalemia hypokalemia spironolactone
bNP diastolic_ dysfunction
dopamine nesiritide decongestion renal
NT-probNP
g-protein-coupled receptor_ kinase
imaging techniques systolic_fonctionnement HFpEF long_axis_fonctionnement
ST2 amino-terminal_pro-B-type natriuretic_peptide
anemia iron_deficiency MEDLINE cochrane_ Library
hospitals
creatinine bNP furosemide_ dose oxygen_ flow dobutamine norepinephrine
biomedical treatment CHm biomedical treatment dCM heart_ failure PubMed
myocardial_ collagen
sst2/high-dose BB sst2 figure cardiovascular_ event
Sprague-Dawley sham aCF allopurinol
biventricular_pacing biVP cardiac_ output co cardiac surgery
saxagliptin sitagliptin pairwise
kccq HFpEF cronbach
implantable implantable_ cardioverter_de_fibrillator-cRTLBBB QRs
alendronate- etidronate raloxifene-tre
clinical_ trials
systolic HF Danish Heart_ Failure_db new-onset ESRD Danish Registry_ on_Dialysis
Chemotherapy trastuzumab CHF Diseases Healthcare_ Common_ Procedure codes
contemporary_ heart_ failureHF therapies HF ventricular_ ejection_fractionLVEF
ct hazard
transplantation consultation MT
Hospitalized_ Heart_ Failure Saxagliptin sitagliptin antihyperglycemic Drugs
Race_training chronic_ heart_ failure Heart_ Failure
intraclass_ correlation_coefficient icc kappa coefficient mdc
Nicorandil phosphocreatine adenine nucleotides mitochondrial oxidative phosphorylation creatine_ kinase
implantation LV implantation heart_ failure
neurohormones adipokinescc progressive loss fat_ free massfm fat massFM
Swedish_national_inpatient_ Registry rehospitalization stroke myocardial_ infarction heart_ failure caBG
mistargeting rad Q66p RGK protein efficacy
catheter ablation AF hff ventricularLV ejection_fraction
Myocyte_ hypertrophy heart_ failure
magnetically_ levitated lVAS Seattle Heart_ Failure
AlphaLISa immunoassays antibodies circulating NT-probNP
cardiac_ plasma membrane s1PR1 deleterious β1AR_ overstimulation heart_ failure
New York_ Heart_associationNYHA class_ III_chron_ heart_ failure ejection_fraction
biological_ phenotype
tunel
SDQT HFVT hnorm β-adrenoceptor_blockade esmolol
surgically_ induced myocardial_ infarction heart_ failure bisoprolol vehicle
ss HH TM medical_support office_ hours mortality discharged patients heart_ failure
transitions_de_capitaux congestive_ heart_ failure
tachycardia intravenous atropine cardiac_vagal_ tone CHF-DNx CHF-inV
cardiomyocytes humoral stimuli myocardium conditions
passage-force RV LV_ dysfunction
biventricular_support RVADs
functional_ efficacy hno donor myocardial_fonctionnel HF
transitions_de_care
ESRD outpatients systolic_f egf
CHF cardiac_ explant c-Kit
BB therapy
implantations heart_ failure h acute_méocardial_ infarction pneumonia
heart_ failure left ventricular_ ejection spironolactone Kaiser_ Permanente_ Northern California
echocardiographic score LV reverse_ remodeling LV end-systolic
preoperative renal dysfunction cardiovascular eventsstroke myocardial infarction heart_ failure coronary_ artery_ bypass graft
aldosterone_ antagonist_therapy heart_ failure post-myocardial_ infarction_ heart_ failure
left-to-right interatrial_ shunting heart_ failure ejection_fraction
myocardial_ extracellular matrix cardiac_ magnetic_réonance
bmi heart_ rate rhythm lying blood_tension valvular disease pulmonary_congestion
Peritoneal_dialysisPD diuretic_ resistant_ volume_ overload heart_ failureHF
Cardiology_practices national_ Cardiovascular_ Disease_ Registry Clinical_ Excellence
hno donor cXL-1020) myoctyes intact hearts heart_ failureHF
peripheral_ muscle_pump cardiac_ filling subpulmonary ventricle Fontan_ circulation
Nicorandil heart_ rate aortic_ blood_ flow mitochondrial_ oxidative_ stress doxorubicin cardiotoxicity
Renal_ dysfunction heart_ failureHF dysfunction end-stage_ renal disease eRD
heart_ failure preserved_ ejection_fraction hff heart_ failure
Peripheral_ artery diseasePAD heart_ failureHF HFPAD
heart_ failure CHARM candesartan_ in_ Heart_ Failure Mortality Morbidity
pediatric FontanPF catheterization
ms subvalvular dynamic annular MS
Lancet anoop Shah air pollution heart_ failure morbidity mortality
implant-derived_progenitor_cells
obese hfff caloric restriction aerobic_ exercise VO2
anemia HF health-related quality_of_ lifeHRQoL HF
mRI dyssynchronous_nonfailing HF canine_électromechaniques remodeling
HR_ variability mortality AMI CHF/LV
race chronic_ heart_ failureHF
drug-free
cell_ senescence active malignancies cancer prostate colon osteoporosis depression dementia
capillary coronary_perfusion ad-flk rats ad-c rats
shuttle_ walk_test body_ mass hand_ grip_ strength
physician_ volume mortality internists cardiologists
protocol-driven POc NP consultation ED throughput
Troponin_t n-terminal_pro-b-type_natriuretic_peptide biomarker heart_ failure atherosclerosis
RV_ failure pulmonary_ arterial_ hypertensionPAh pulmonary_ embolism
tachycardic_ response methylatropine vagal_ tone bradycardic_ response propranolol
Neprilysin_ inhibitors natriuretic_peptide breakdown atrial natriuretic_peptide b-type_natriuretic_peptide
économique_analysis Patient_management_ Interventions Heart_ Failure coût-efectiveness disease_management_ programs_ in_heart_ failure
Fractional_fréquence_ reserve positron_ emission_tomography ischemia bottleneck ventricle LAD
cardiac_resynchronization_therapy cRT heart_ failure hz QRs ejection_fractionEF
mitochondrial_ oxidative_phosphorylation creatine kinase oxidative_tension
ventricular_assist devices cardiac nurses gastrointestinal_ bleeding
spironolactone death hyperkalemia kidney injury
cardiac transplant ect transplant
MI-induced septum_synchrone_ thickness LV posterior_ wall_ thickness LV internal_ diameter metoprolol
BAT n-terminal_pro-brain_ natriuretic_peptide HF
American_ College_of_physiques aCP anemia iron_deficiency heart
mortality cardiovascular mortalityHF
HF HF eff hpf
electrical stimulation peripheral muscles endothelial_fréquence heart_ failure ventricular_ ejection_fraction
SDQT-to-SDRR HFVT hnorm
ventricular structure geometry fibersheet orientation
rad_q66p cardiomyopathy
serum_ resistin women anthracycline-containing_chemotherapy cardiotoxicity
sst2 fréquence cardiovascular
preoperative_hyalbuminemia
renin-angiotensin_system_blocker beta-blocker therapy heart_ failure ventricular_ ejection
Medical Therapies Cardiac_ Function Breath Lung_congestion
cardioprotective_effet nicorandil hemodynamic_ alterations mitochondrial_ dysfunction doxorubicin rats
Baroreflex sensitivity temps heart_ rate_variable hv CHF-inv sham-inv sham-inv renal DNx
haematopoietique_cell transplantation hct congestive_ heart_ failure chf hct anthracyclines
epigenetic_writer proteinshistone_acetyltransferases epigenetic_erasershistone_deacetylases cardiac
NT-probNP mortality HF
inhibition mir-25 cardiac_ dysfunction murine_myocardium heart_ failure Hand2-dependent
electrical_activation dyssynchronous_ heart_ failureHF electromechanical_ behavior heart
nurse cognitive impairment physician discharge elderly patients heart_ failure
hypertension hg diabetes mellitus systolic diastolic murmurs
heart_team cardiologists cardiovascular surgeons medical
Chinese_ herbal medicine chm dilated_ cardiomyopathy dm heart_ failure
TAPse PASp nonsurvivors hff HFpEF
RV pulmonary_ embolism mortality
bisphosphonates alendronate etidronate heart_ failure refill
HF-action HF ejection_fraction
carvedilol β-blocker β-blocker metoprolol thromboembolic events heart_ failure
HF AMI pna mortality
cardiac transplant
heart_ failureHF HF
remodeling arrhythmia_ substrate AMI HR
hypertension hfEF DASh_sRD sodium
emd dyssynchronous HF remodeling
ejection_fraction cardiac index inotropes inotrope
doxorubicin-induce cardiotoxicity Hum-retn littermate resistin retn
diastolic_ dysfunction pathophysiology HFpEF non-diastolic_ abnormalities cardiovascular
8-fluo-cAMP binding phosphomimic Ser77 ser83 mutant RIα double_mutant WT_riα
high-density_ lipoproteinHDl endothelial-protective effects endothelial_cell e nitric oxide
dialysis HF hospitalization mortality HF
admission_à_discharge hospitalized_ older adults heart_ failureHF Nursing_outcomes_ Classificationnoc
hf saxagliptin sitagliptin antihyperglycemic agents
preoperative albumin mortality lVAD implantation
systolique_ heart_ failure QRs cRT hospitalization heart_ failure mortality
dgs non-ischemic ischemic heart_ failure
bleeding driveline_ infection gastrointestinal bleeding stroke
cox_regression models propensity_ score_decile oral glucocorticoid HF loop_diuretics
insulin_ resistance diabetes insulin_ receptor substrates i rs insulin-signaling
dyssynchronous HF electromechanical_delay ed myocyte_depolarization myofiber
Beta_blockers mortality readmissions heart_ failure ejection_fraction hrf heart_ rateHR
Functional_electrical stimulation fes emotional stress endothelial_fonctionnel heart_ failure
droit_ atrial_Myxoma pulmonary_ arteries right_ atrial_ mass_ removal pulmonary_ embolectomy
transplant_ ineligible patients PD HF volume_managementPD
biomarker-guided_ clinical_ trial therapeutic multimarker-based
SAF abnormal liver_ texture
Frailty biological_ phenotype weak_ grip_ strength physical_ exhaustion
cRT-d IE IC cRT-d IEs
eds discharge patients heart_ failure ED
QRs morphologie cardiac resynchronization_therapy resynchronization-Defibrillation Ambulatory_ Heart_ Failure_trialRAFt
acute_ right_ heart_ failure therapy_refractory_ cardiogenic_ shock heart corporeal_ membrane_ oxygenation emo cPRICU
office-based emergency room_practitioners heart_ disease HF
Bax bcl-2 mRNA heart_ failure bcl-2/Bax
heart_ magnetic_ resonance_ imaging chelation_ choices patient_ compliance heart_ failure arrhythmias
nitroxyl hno Angelis salt inotropic lusitropic vasodilator cAMP
ejection_fraction ef pre-PD NYHA ventricular_ dysfunction
cPCs early-outgrowth e-cFUs circulating CD34 vEGFR
coût-effectives continuous-flow lVADs heartMate hm_ II HeartWare bt DT
anticoagulation rate_control cardiovascular complications cardiovascular_ death acute_ heart_ failure atrial_ fibrillationAF
EF
bp bNP inhospital_ mortality
DASh mortality HF Mediterranean_diet scores
skeletal_ muscle_ mass figure
ST2 functional_ capacity well-treated ambulatory patients HF
Quality_of_ life mortality
cardiomyocytes jq1 drug phenylephrine-induce genes
accka polymorphism heart_ failure glomerular_ filtration_ rate RENAStur
cardiovascular diseases heart_ failureHF
cardiac_veGF expression Akt endothelial_no synthase_activation drug-untreated failing_hearts
Psychosocial Factors Heart_ Failure Heart_ Failure h-action
heart_ failure ventricular_synchron_ dysfunction BB
derivation_cohort coronary_ angiography systolic HF unclear etiology
cardiac insulin-resistance aac insulin-stimulated rates glycolysis glucose_ oxidation plasma membrane translocation glucose_transport
angiotensin_II angII hypoxia sCN5a mRNA splicing sCN5a
ventricular_contractile_ reserve exercise-induced PASp
arterial_ elastance end-systolic elastance ventricular-arterial coupling ees techniques
post-DASh rs_sRD_ brachial_central_ blood_tension radial_ arterial_ tonometry cardiovascular_fonctionnel echocardiographic
Gene expression grse9128 Gene_ Expression_ Omnibus heart_ failure ischemic
rhythm_control therapy antiarrhythmic drugs catheter ablation electrocardiographic device rhythm
expenditures noncardiovascular diagnoses implantable cardiac_arrhythmia devices noncardiovascular drugs
HF reduced_ ejection_fraction hrEF hpf
extracorporeal_ life_support bridging_therapy acute_ischemic_ right_ heart_ failure refractory_ cardiogenic_ shock reperfusion therapy
heart_ failure left ventricular_ ejection_fraction Fes endothelial_fonctionnement HFpEF
intubation
hearts tgtetMena_mice wild-type_ littermates heart_ mass transgenic_mice
raloxifene
hff respiratory_gas
guideline-recommended drugs heart_ failure biomedical reasons
black_race HF exercise_ performance HF
Wasting_de_ fat lean_ mass fat_ loss catabolism adipose_ tissue cardioprotective HF
lVADs CF devices HeartMate_II devices Thoratec_ Corp Pleasanton_ Calif hVAD hVAD HeartWare intl Framingham Mass
hearts_de_ fish_ lacking nucleolin developmental_ impairment chamber_ patterning functional defects cardiac_ looping myocyte
HF immunoreactive NT-probNP c-terminal_ truncated_ fragments NT-probNP
FM plasma NPs adiponectinfffm NPs adiponectin
Macrophages cardiomyocytes Hum-retn mice doxorubicin hretn mRNA protein expression
beat-to-beat QT_ interval surface eCGs atrial_pacing esmolol isoprenaline atropine infusion
sympathetic tone parasympathetic_ tone heart_ rate metoprolol atropine
EH HFpEF hff hff therapy
acute_Myocardial_ infarction congestive_ heart_ failure

hospital_quality_ improvement
cardiac_ tissue mice TAC- sham-operated jq1 BET implantation pathological_ cardiac_ gene expression
Power_ spectral_analyse low-frequency_high-frequencyfff CHF-inv sham-inv sham-inv DNx
natriuretic_peptideNT-probNP misdiagnosis heart_ failureHF
HF-action ventricular_ ejection_fraction New York_ Heart_association IV HF
myocardial DD collagen_deposition titin diabetic zSF1 rats heart_ failure
cardiac_ magnetic_ resonance hff biomarker hff
contractility ventricular-arterial coupling SV ivabradine-treated
conditional_ gene-targeted Hands pression-overload-induced hypertrophy fibrosis ventricular_ dysfunction fetal
NT-probNP ed HF
clinical_ prediction_ rule CAD angiography systolic_HF coût
epigenetic readers cardiac_biology cardiac_ gene_control chromatin-dependent signal_transduction abrogate_pathological_ gene expression HF
Systolic_ blood_tension left_ventricularLV hypertrophy
heart_ failure cardiac transplant
catheter-based_percutane_revascularization angioplasty stenting
load-corrected chronotropic_ response heart_ rate
Peak_ oxygen_ consumptionVO2max hz
cox-proportional_ hazard models negative_binomial_ regression models
HF t2d ERC treadmill_ testingVO2max oxygen biopsies
hospital gastrointestinal_ bleeding ventricular_tachycardia storm heart
β-AR stimulation catecholamine infusions pde2 cAMP hydrolytic activity blunted_ cardiac β-AR responsiveness
HF QRs prolongation LVEF cRT reverse_ remodeling LV
chronic pAH RV_decompensation pharmacologic therapies RV_ failure_management pAH

comanagement clinicians medication
non-frail h severe_frailty h Gill HF
frailty Health ABC_short_phyal_ Performance Battery hABC_ Battery Gill HF
RV_support lVAD cardiogenic_ shock myocardial_ infarction chronic_decompensation_heart_ failure
Chronic_ heart_ failure chf multisystem_ disease anemia insulin_ resistance autonomic_ dysbalance cardiac_ cachexia
Xanthine oxidaseXO rat ventricularLV myocytesvo mitral_regurgitation aortocaval_f
obese ZSF1 heart_ failure ejection_fraction lung ventricular ejection_fraction left_ventricular DD
high-volume physicians mortality low-volume
Western_ Australian_linked_administrative_ health
conditions Turkey
nursing-sensitive
HF am odds
miRNAs RNAs RNAs binding messenger RNA
free-breathing pulse_ sequence myocardial changes swine tachycardia-induce heart_ failure
HFpf ivabradine
PF_cohort New York_ Heart_association
eds responsable diagnosis_de_ heart_ failure
Cardiac c-Kit cardiac explant-derived cells cardiac_organs myocardial_ infarction
pathophysiology HF medical management pathophysiologic
inhibitor jq1 BETs chromatin suppression RNA_polymerase_ II
NPs pulmonary_ embolism diabetes chemotherapy
empirically_ derived_composite_quality_ measure heart_ failure h acute_méocardial_ infarction pneumonia pna
intestinal_ dysfunction intestinal_ barrier chronic_ inflammatory_ state catabolic_anabolic_ imbalance cardiac_ cachexia CHF
heart_ failure ejection_fractionHFpEF
cyclic_adenosine_ monophosphate cAMP cyclic_ guanosine_ monophosphate cgm failing_ hearts
mortality healthcare_ utilization telehealth congestive_ heart_ failure chronic_ obstructive_ pulmonary disease diabetes mellitus
catheter ablation atrial_ fibrillationAF heart_ failure hfff
ischemic-hypertensive_ cardiomiopathy angina inducible_méocardial_ischemia coronary_ arteries
RA methotrexate tNF_ antagonist non-biological disease antirheumatic drugnbDMARD
cox proportional_ hazards_regression_modelling ie acute_ coronary syndromes coronary
sphingosine-1-phosphate receptor s1PR β1-adrenergic receptorβ1AR g-protein-coupled_ receptors heart
septal PCWP
inappropriate therapy atrial_ fibrillation carvedilol metoprolol
grs LVEF sa CV
Bradycardia implanted metoprolol cardiac_ sympathetic_ tone CHF-inv rabbits sham-inv CHF-DNx
cPG-recommended pharmacological treatment device ventricular
Nordic_ walking cardiac rehabilitation_de_fonctionnel_puissance
rad_q66p inhibitory actions rad cav1.3 l-type_ channel_isoforms heart
EF LCx LAD stent infarcted left ventricle LCx LAD
signalling cascades microRNAs bHLh transcription_factor Hand2 postnatal_ mammalian_ myocardium embryonic_ genes heart_ failure
ERC ERC DAPc protein sarcomeric_microstructure Skm myofibre_ regeneration
mva implantation leaflet_ motion leaflet_réection edge-to-edge anastomosis
hART New York_ Heart_ AssociationNYHA HF self-management_ counseling HF
BET_bromodomain_ proteinsBETs acetyl-lysine_ reader_ proteins HF
cardiac_fonction echocardiography diastolic_ dysfunction ejection_fraction
aldosterone_ antagonism heart_ failure aldosterone neurohormone electrolytes heart_ failure
EH LV_comp compliance vLV_ end-diastolic_puissance hg coefficient ml
Grade
HF
vent_ circulatory_ failure
l-type_voltage-gated ventricular action excitation-contraction e couplage myocardium
AT1 receptors neprilysin blocks renin-angiotensin-aldosteron RAS vasodilatory diuretic
ivabradine ventricular_ filling heart_ failure hpEF
transfusions iron erythropoiesis-stimulating agents anemia congestive_ heart_ failure coronary_ heart_ disease transfusion
bNP glomerular filtration_ rate hypertension transmitral e-wave diastolic_metral_ annular
β-blockade disease_ progression cAMP-dependent protein_ kinase pKA β-adrenergic receptor
erythropoiesis-stimulation_agent_therapy benefits venous_thromboembolism
clinical genetic CHF
black_race mortalityhazard ratio cardiovascular mortalityHF
percutaneous_ one-vessel_model_for_ chronic_Myocardial_ischemia stent polytetrafluoroethylene bottleneck
Centers_for_ Medicare_ and_ Medicaid services cms mortality readmission penalties
heart_ failureHF tumor_ necrosis factorTNf tNF_ antagonists HF
signal_transduction_ cascade transcription factors cardiomyocytes transcription factors chromatin_ structure
hazard_modellen follow-up physician discharge death
multivariable logistic analysis oxygen_uptake metabolic exercise cardiac kidney HF
annular size_reduction surgery diastolic_metral_ valve_ tethering anterior leaflet_ opening papillary_ muscles ventricular_dilatation
hypertensive hfff sodium-restricted DASh ventricular_ diastolic_fonctionnement arterial_ elastance ventricular-arterial coupling
CHF hct polymorphisms anthracycline metabolism iron_ homeostasis anti-oxidant_de_fence myocardial remodelling
figure CAD diameter_ stenosis
heart_ failure acute_méocardial_ infarction
aldactone_ Evaluation_ Study cardiovascular_ failure aldosterone_ antagonist spironolactone mortality
medication nonadherence salt
pathophysiological
lVAD
scientific_ literature hm_ II HeartWare_ patients hm II
creatininehazard dL
implantation lVAD implantation implantation implantation bt dt medical therapy
radial_ artery_ tonometry
HR variability_turbulence
dopamine nesiritide renal fonction acute_ heart_ failure renal_ dysfunction
risk_de_ death glomerular filtration
Medicare coverage breast cancer chemotherapy sEER-Medicare Texas Cancer Registry_Medicare
signalosome_ complex scaffold_ protein kinases sequential_phosphorylation
magnetically levitated centrifugal-flow_ chronic lVAS
cardiomyocytes pde2 activity cgMP nitric oxide pde2
ejection_fraction b-type_natriuretic_peptide heart_ Failure
beta1-adrenergic receptor sphingosine-phosphate receptor s1PR cardiac hypertrophic heart_ failure s1PR cardiac gene therapy
ECs HDl phosphorylation eNOS-Ser eNOS-Thr PKc-βII-Ser p70s6k-Ser
RCTs sts hm sts TM
mouse ventricular_Myocytes sarcomere
administrative databases Alberta discharged_ alive hospital heart_ failure
PASp
ct_on_ assignment time_ to_ death hf
heart_ failure myocardial_ collagen tissue
l-dKO mice cardiac iRS1 iRS2 heart_ failure impaired cardiac_énergie_ metabolism protein_ kinase
nicorandil doxorubicin-induce heart_ failure hemodynamic perturbations mitochondrial_ dysfunction ultrastructural antitumor
Rhythm_control therapy af atrial structure sinus rhythm rhythm
RR heart_ failure bisphophonates crude RR
physician_adherence guideline_ recommendations heart_ failure Clinical_ Practice_ Guideline cg heart_ failureHF
acute_ heart_ failure renal dysfunction dopamine nesiritide renal_fonctionnement diuretic therapy
HF implant_ thickness dual-energy X-ray_ absorptiometry echocardiography blood
high-cost Medicare fee-for-service_ beneficiaries Centers_de_ Medicare Medicare Medicaid services propensity-score
hospitals heart_ failureHF conditions acute_Myocardial_ infarction pneumonia conditions
Patients heart_ failure
kccq New York_ Heart_association HFpEF HF ef
aCP restrictive_ red_ blood_cell_transfusion stratégie_trigger_ hemoglobin dl hemoglobin
implanted left-to-right interatrial_ shunt haemodynamic heart_ failure ejection_fraction
Caloric_restriction Aerobic_ Exercise Peak oxygen_ Consumption Quality_of_ Life Heart_ Failure ejection_fraction
ventricular_assist devices lVADs chronic end-stage_heart_ failure bt transplant-ineligible patients dt
ventricular-pulmonary_ arterial couplingpulmonary_ vascular resistance right ventricular_ ejection_fraction
carvedilol metoprolol implantable implantable_ cardioverter-de_de_fisbrillator_therapy MADit-cRT multicenter_automatic_deibrillator implantation Cardiac_resynchronization Therapy
glucocorticoids HF
HR ivabradine Ea TAC
HFPSI risk_de_ death medical hospitalization HF HF
CHm adjunctive dCM heart_ failure
carvedilol inappropriate therapy metoprololhazard
testosterone rehabilitation CHF testosterone
VO2 lean_ body_ Mass change_ in_terme_système intermuscular_ fat
guidelines-Heart_ Failure hf ef
cox_model
cardiac insulin-resistance mitochondrial_ oxidative metabolism cardiac_ hypertrophy energie_ deficit hypertrophy heart_ failure
rad rem rem rem2 rad rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem rem_g_g proteins ventricular_action EC coupling cardiac_l-type_active
implantular_ size_reduction surgery diastolic_metral_ valve_ tethering anterior leaflet_ opening papillary_ muscles left ventricularLV
pathophysiology heart_ failure preserved ejection_fraction hff myocardial_ extracellular_ matrix accumulation
breathing_control cardiac_ arrest pulseless ventricular_ fibrillationPVf implanted cardioverter-de_fibrillator
n-terminal probNPNT-probNP midregional proANpMR-proANp adiponectin CHF bmi FM
acetylcholinesterase inhibitor_ pyridostigmine sympathovagal_ balance cardiac_ remodeling cardiac HF myocardial_ infarction
cardiac_ sympathetic activity i-meta-iodobenzylguanidine i-mBG β-blocker
Swedishweb-system evidence-based_care Heart_ disease Recommended Therapies caBG Sweden
LVEF reverse remodeling temps HF
brain_ natriuretic_peptide bNP bNP bNP
pde_ superfamily pde2 cgmp cAMP_hydrolysis negative cross_talk cgmp cAMP signaling
TAPselongitudinal RV_ fiber_ shortening PASpforce RV in vivo RV_ length-force
mitochondrial-targeted antioxidant protectionive_peptides Szeto-Schiller SS cardiac fonction proteomic remodeling
économique_ Analysis Patient_management_ Interventions Heart_ Failure Cost-Effectiveness_ Model coût-effectiveness disease management_ programs_ in_heart_ failure
re-hospitalization admissions
coprimary_ end points cumulative_ urine_ volume décongestion serum_ cystatin crenal_fonction_ end point
cardiac_ arrest cardiopulmonary_ resuscitation cPR posterior_ wall_ infarction cardiac
diabetes saxagliptin sitagliptin pioglitazone sulfonylureas insulin
hyperkalemia mineralocorticoid_ receptor_ antagonists race mineralocorticoid_ receptor_ antagonists heart_ failureHF
aCP erythropoiesis-stimulation agents anemia congestive_ heart_ failure coronary_ heart_ disease
heart_ failureHF ejection_fractionrEF renin-angiotensin_systemRAS β-blockers
uPR scc5a ventricular_ systolic HF implanted pluripotent stem_cell-derived_ cardiomyocyteshiPSc-CMs
coPD CHF cRF ICC kappa coefficients
implantable implantable implantable cardioverter-de_fibrillator implant end-of-life
heart_ failure left ventricular_ ejection_fraction
heart_ failure myocardial_fréquence children dilated ventricles
cochrane_ Effective_ Practice Care_ Taxonomy
mouse_rad_q65p murine_ equivalent_of_ human rad Q66p l-type_ currents caV
implantable implantable cardioverter-de_fillator_de_activation implantable_ cardioverter-de_fillator_ shocks
mouse_ heart_ failureHF hypertensive_ heart_ disease hdh therapeutic hd
MI hf
Medicare patients acute_care hospital HF AMI pna
ctnt NT-probNP aRIC_ff model aucs continuous NRIs
Card_vascular_ events sst2 ml ml metoprolol_ succinate
incubation_de_ EC HDl NYha-IIIb phosphorylation eNOS-Ser phosphorylation eNOS-Thr HDL
HF LVEF long-term_ mortality LVEF
sarcoplasmic_ reticularSR ca(2+)-uptake protein rs ca(2+)-pump phospholamban infarcted_ hearts metoprolol
ventricular_ longitudinal_synchrone_ strain grLS left ventricular_ mechanics cardiovascularCV atrial_ fibrillationAF
early-onset HF HF EF HF HF MI
carvedilol Willebrand_ factor metoprolol β2-adrenergic receptor_haplotype
inmuscular testosterone_ supplementation cardiac_ failure chf testosterone
heart_ failure HF plasma b-type_natriuretic_peptide bNP ejection_fraction ef HF sex
grLS ventricular_ ejection_fractionLVEF systolic_metral_ annulus_ velocity CV
RM implanted_monitoring implanted_ implanted_monitoring_ devices medical support sts contact hm
Timed_up_go tug chronic_ obstructive_ pulmonary diseasecoPD chronic_ heart_ failure chf chronic_ renal_ failure cf
temps-dependent cox_regression_analyse beta-blockers beta-blockers inappropriate therapy antitachycardia_pacing aTP shock therapy
ethically_ complex situations pediatriques families religious_ beliefs life-sustaining
patient_ preferences priorities guideline-recommended medications medical records performance
coût rhythm-control rate-control
ventricular ejection_fraction egf
CD34_vegf2_cells functional_puissance CD34_vegf2_cells VO2
fit unfit cRF hazard ratios unfit_ men obese
Medicare Patient_ Safety_monitoring_system mSMS adverse_ event_ rates acute_méocardial_ infarction congestive_ heart_ failure pneumonia conditions surgery
HFPSI blood_ urea_ nitrogen b-type_ natriuretic_peptide New York_ Heart_association diabetes atrial_ fibrillationflutter
cRT
figure-fatality HF
implants heart_ failure ejection_fraction
CHF race_ethnicity anthracycline exposure stem_cell
tension_fpassive-sarcomere_long_terme muscle_ strips kcl-KI treatment titin extracellular_ matrix Fpassive
aerobic_de_réquence_training avantages exercise_puissance muscle_ strength cardiac NT-probNP inflammatory i6 hsCRp
hospital_ performance readmission aCR Potential_ Preventable_ Readmission pPR Centers_de_ Medicare Medicaid cm
reversibility heart_ failure myocardial_ infarction m β-adrenoceptor_blockade infarcted_ rats metoprolol
rehabilitation
congestive_ heart_ failure ed
arginine_ vasopressin aVP physiologique_processes CHF inhibition aVP vasopressin_ receptor_ antagonist_therapy CHF
implantable_defibrillators circulatory_ support transplantation heart_ failure
rats hearts caspase phosphocreatine adenine_ nucleotides cytochrome bcl2 Bax caspase
ventricular_pacing Bax bcl-2 Caspase-3 RTq-PCr interventricular_ septum biopsies beagle dogs heart_ failure
angiotensin-converting enzyme inhibiteursangiotensin_ receptor blockers β-blockers heart_ failure ejection_fraction
sodium-restricted hypertension dietDASh sd ventricular_ diastolic_fonctionnement arterial_ elastance ventricular-arterial coupling hypertensive hff
acute_f trials RELAx-aHFASTRONAUT PRONTO patient_enrollment
metoprolol carvedilol sympathetic_ activity Willebrand_ factor
Hospitalized HF Diseases Clinical_ Modification codes principal discharge
rad_q65p gating_ movement wild-type rad Q65p l-type_ channel_ inhibition RGK proteins
heart_ failure proteomics changes actin_cytoskeleton_pathways SS20 mitochondrial metabolic pathways
echocardiograms left ventricular base midpapillary apex IVc biVP STE twist basal rotations CS RS synchrony
pyridostigmine coronary_ artery_ ligation cardiac_vagal sympathetic_ tone cardiac remodeling ventricular_ dysfunction HF
New York_ Heart_associationNYHA class_ II_ Heart_ Failure eplerenone implant-HF
discharge follow-up
life_ expectancy heart_ failure
heart_ failure_discharges University_of_connecticut_health Center
Pulmonary_caillary_wedge_tension hg hg right_ atrial_tension pulmonary_ arterial_tension pulmonary_ resistance
acute_heart_ failureHF pharmacologic studies calcium-sensitizing agents endothelin vasopressin adenosine
aortic_insufficiency i mechanical_ circulatory_ support continuous_fréquence ventricular_assist devices lVADs pulsatile devices
HF HF phenylephrine haemodynamic_ stress surgical transverse_aortic_constrictionTAC jq1 cardiac_ hypertrophy
drugs RAas direct_renin inhibitors endopeptidase inhibitors vasopeptidase inhibitors angiotensin receptor_blockers
pde2_overexpression healthy_ cardiomyocytes cAMP l-type_ca2 inotropic_ effect β-AR basal_contractility
bottleneck_ stent implanted left_ anterior_ descendingLAD proximal_ circumflex artery lx proximal LCx LAD
acute_méocardial_ infarction AMI heart_ failureHF AMI
i-mg cardiac_ washout carvedilol metoprolol β2-adrenergic receptor
Muscle_ aerobic_ capacity postexercise_phosphocreatine_resynthesis Fontan
Cardiac_resynchronization_therapy cRT dialysis-dependent patients heart_ failureHF cRT dialysis
efficacy eplerenone hyperkalemia renal fonction EMPHASIS-HF epleren_in_ Mild Patients Hospitalization Heart_ Failure
h-dKO ventricular mass cardiac_ apoptosis fibrosis
inappropriate ATP shock therapy
cardiorespiratory_ fitness crf body_ mass index heart_ failureHF cardiovascular_risk factors HF
hospitalized_heart_ failure hHF dipeptidyl_ peptidase-4 dp-4 antihyperglycemic agents
quality_ improvement database multivariable_cox modeling Heart_ Failure_ Patient_ Severity_ Index hPSI University_de_ Michigan HF
cardiac patients acute_méocardial_ infarctionAMI congestive_ heart_ failure chf left_ventricularLV
neonatal rat ventricular_ cardiomyocytes chronic insulin iRS1 iRS2 insulin action cardiac_ dysfunction insulin_ resistance diabetes
echocardiograms left ventricular_ midpapillary atrioventricular_delay avd interventricular_delay vd ste radial_ strainRS
New York_ Heart_ AssociationNYHA functional class_ III HF ejection_fractions chronic_directed_ medical therapyGDMT
bb QRs
pka regulatory rIIα catalytic cα phosphorylation hz
dyssynchronous HF myofiber septum depresses myofiber stretch_ rate
CHF c-Kit transforming_ growth_factor-β tGF-β epithelial mesenchymal transition pluripotency shams
label-free shotgun proteomics transverse_aortic_constriction TAC heart_ failure
hff ventricular_ ejection_fraction hfpEF left_ventricular_ ejection_fraction RAS- β-blocker HF
p70s6 k PKc-βII HDl jha-IIIb malondialdehyde bound HDl
g-protein-coupled receptors reciprocal_ regulation mouse hearts β-adrenergic_ receptor_stimulation rat postischemic_heart_ failure
weight
NT-probNP inflammatory_ biomarkers hsCRp IL
sex ejection_fraction frail biological_ phenotype
resting_HR VO2max
tf-β inhibition c-Kit_cell implantation cardiac_progenitor_ function cell_ expansion
BETs neurohormonally_ induced_ heart_ disease jq1 phenylephrine-mediated hypertrophy cardiomyocytes pathological gene induction
concentric_ remodeling cr concentric_ hypertrophyCH left_ ventricularLV implanting heart_ failure ejection_fraction hpEF eccentric hypertrophyEH
BAT implantal_pro-brain_ natriuretic_peptide burden heart_ failure GDm-treated NYHA
MLHF
h-Innervated sham-inv nonpace dx sham-dx pace_non-dx chf-inv pace_ DNx chf-DNx
PSs btes
hemoglobin hgb HRQoL training-induced changes HRQoL patients Heart_ Failure hf-action
Risk RV_ dysfunctionhazard figure cachexiahazard
atrial_fbrillation congestive_ Heart_ Failure expenditures Québec rhythm rate-control
calcineurin_nfat mr-25 expression helix-loop-helix bHLh Hand
heart_ failure myocardial_ischaemia bradyarrhythmias valvular_regurgitation pulmonary embolism renal dysfunction
hABC_ Battery_ score HF health ABC HF hf_model SD death
NT-probNP
prognostic_puissance r-r interval_ oscillations HR_ variability fractal_ scaling
heart_ failure HF ventricular_tachycardia ht VT hnorm
grLS cox model chronic_ heart_ failure hypertension diabetes stroke glomerular_ filtration_ rate LVEF
diastolic_ filling_ formalism relaxationviscoelastic passive_stiffness doppler_ mitral inflow e-wave
VAD ventricular_assist_ device_support ECmo extracorporeal_ membrane_ oxygenation_ membrane VAD
mt NYha HFpEF hff HFpEF
cost-effectiveness heart_ failure_ disease_management
resistin heart_ failure humanized mouse murine_ resistin transgenic Retn_ gene hum-retn_mice inflammation-stimulated resistin
angiotensin-converting enzyme inhibiteursangiotensin receptors β-blockers
tttMena_mice cardiac_ injury ejection_fraction fraction heart_ dilatation hypertrophy transverse_aortic_constrictionTAC
heart_ failure Italy cfa SCHf Self-Care_ Maintenance Self-Care Management Self-Care_ Confidence
resynchronization-Defibrillation Ambulatory_ Heart_ Failure implantable cardioverter_de_fibrillator-cRT mortality heart_ failure
ischemic events ies ischemic_ cardiomyopathyIC cardiac_resynchronization_therapy defibrillator cRT-d
renal dysfunction chronic_ obstructive pulmonary disease diabetes peripheral_ vascular disease left ventricular_ ejection_fraction iCD shocks ischemic_ cardiomyopathy
CHF SD testosterone
Raf-MEK_1/2-erk scaffold_ proteins adaptive maladaptive cardiac remodelling
functional MS LV dilatation heart_ failure HF LV functional MS HF MR prolapse degenerative_mral valve
angiotensin converting_ enzyme_ inhibitor angiotensin-receptor_blockers β-blockers heart_ failure
New York_ Heart_association kccq symptoms HF ef HFpEF
LV ejection_fraction LV strain_de_strain_ rate systole diastolic indices LV strain_ rate diastole transmissionral_fréquence sinus rhythm
c57b angle_ II infusion uninephrectomy ANG_ II infusion salt_ loading ANG infusion uninephrectomy salt
transmissionral_ blood_ flow_fréquence doppler_ early_ diastolic_metral_ annulus pulmonary_caillary_wedge_tension pWP systolique_ heart_ failureHF
VO2 exercise masse
AMI hospital
kccq HFpEF
sex-specific model ctnt NT-probNP ctnt NT-probNP HF
Mass_spectrometry n- c-terminally_processed_ forms circulating NT-probNP physiological_ proteolysis leu3-gly
HFpEF patients New York_ Heart_association mean_ ejection_fraction
depressed_ left_ventricularLV pressure pressure ejection_fraction fraction_ shortening cardiac_ output LV end-diastolic_tension MI metoprolol
baroreflex_ Activation Therapy Heart_ Failure Reduced_ejection_fraction
enrollment
HF hf raised blood glucose levels obesity tobacco aging systèmeic hypertensionSH rheumatic fever Chagas disease cd
age-de_sex-adjusted risk hf
hazard cRF
egf egf uncontrolled hypertension diuretics temps ESRD
myocardial_phosphodiesterase-2 pde2 heart_ failureHF pde2 beta-adrenergic receptorβ-AR cardiomyocytes
heart_ failure cardiac_resynchronization_therapy defibrillator implantable cardioverter-defibrillator device carvedilol ATP shock_therapy metoprolol
ERC epicatechin-rich cocoa Skm mitochondrial_ structure ramirez-sanchez ciaraldi perkins Murphy naviaux Hogan ceballos maisel Henry
consultations urgent_ readmission
mena_overexpression TTA mice TAC cardiac_ hypertrophy
p diuretic_refractory_ severe-end-stage HF PD
ATP aac mitochondrial oxidation glucose lactate fatty acids myocardial_ glycolysis
proangiogenic effects b activation VEGF_ pathway adenoviral_ vector decoy VEGF_ receptor ad-flk adenovirus ad-c
eplerenone potassium potassium hyperkalemia medication
implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation implantation proximal LAD LCx reversible_Myocardial_ischemia open stent ischemic_ heart_ failure stent
New York_ Heart_association_ class_ III_ heart_ failure hf ventricular_ ejection p
potassium spironolactone AAs race_de_réquence
cPET CHF exercise rehabilitation
echocardiography LV end-diastolic ml mitral valve mva pressure hg
lVAD aortic_ valve leaflet repair bioprosthetic aortic_ valve_ replacement CF lVAD
veterans VA health_cares systolic_ heart_ failure β-blocker angiotensin_ converting enzyme_ inhibitor angiotensin-receptor_blocker
exercise-induce pulmonary_ artery_ systolic_tensionPASp stress doppler echocardiography right ventricular_contractile_ reserve pulmonary hypertension right_ heart_ failure
MEDLINEEMBAse HEalthSTAR cINAHL cochrane_ Library Campbell Joanna_ Briggs Institute evidence_ Based_ Practice
heart_ failure blockade neuro-hormonal système angiotensin converting_ enzyme_ inhibiteursangiotensin converting_ enzyme_ inhibiteurs_ intolerance mineralocorticoid receptor
open_ chest_model twist RS RS synchrony CS STE rte rvpo RS_synchrony CS biVP
TAPse_passp tAPse-to-passp ratioTAPSe_passp cox_regression Kaplan-meier
obeseSD body_ mass_ index hfff
heart_ failureHF mRNA v voltage-gated_ cardiac na+subunit scc5a truncated_nonfunctional channels endoplasmic_ reticulum
paediatric_ heart_ failure myocarditis dilated_ cardiomyopathy heart_ failure anthracycline malignant_ disease
économique_analysis Patient_management_ Interventions Heart_ Failure Cost-Effiectiveness_ Model
natriuretic_peptidesNPs b-type_NP n-terminal_pro-b-type_NP acute_ heart_ failure Emergency_ Department ed acute_ dyspnea
oxygen_ consumption VO2ven vco2 slope exercise_ oscillatory_ ventilation eOV pressure end-tidal CO2PETco2 cardiopulmonary
Denmark bisphosphonates raloxifene
longitudinal_ strain_de_ left_ventricle echocardiographic_ measurements patients baseline_ echocardiography cRT echocardiograms
hypertension LV dilatation LV dysfunction MR MS mitral_ valve closure organic lesion systolic diastolic_ tethering MR MS
HDl healthy_controls hdl CHF-NYHA-III hdl franc-NYha-II hdl
platelet-activation factorpaf metabolic_ enzymes heart_ failure bmi
acute_care_ surgery acs oHT transplantation medical therapy intravenous inotropes ventricular_assist devicesVADs
renin-angiotensin-aldosterone_system_raas hff angiotensin-converting enzyme_ inhibitors angiotensin_ receptor_blockers aldosterone_blockade HFpEF
HFpf ivabradine ventricular_ filling_tension
admission lVET
heart_ rate blood_tension renal_fonctionnement spironolactone RAS
cardiac_ performance β-adrenoceptor_blockade heart_ failure SR ca(2+)-pump cardiac_ remodeling plasma catecholamines
SS31 congestive_ heart_ failure mitochondrial_ damage TAC mitochondrial_proteome
HF-action HF ventricular_ ejection_fractions HRQoL Kansas City Cardiomyopathy kccq
tolvaptan hyponatremia Japan congestive_ heart_ failure diuretic therapy serum_sodium
dépressed myofibrillar ca(2+)-stimulated ATPase mRNA rs ca(2+)-pump phospholamban α-myosin_ heavy_ chain mRNA β-myosin_ heavy_ chain metoprolol
inesthetized dogs coronary_microembolization-induced HF cXL-1020 ventricular_ end-diastolic_tension myocardial_ oxygen ejection_fraction ventricular_power
heart_ failure t1-mapping
mdc mdc mdc
HF idiopathic dilated_ cardiomyopathy cd ischemic SH valvular alcohol
ST2 functional_capacitation ambulatory patients HF Heart_ Failure Exercise_ Training h-action exercise_training HF
implantable_carvedilol metoprolol implantable_ cardioverter-de_fibrillator therapy MADt-cRT multicenter_automatic_deibrillator implantation Cardiac_resynchronization Therapy
angiotensin-converting enzyme inhibitorsangiotensin receptor_blockers β-blockers
ischemic HF NYHA_ functional_ class_ IV glomerular_ filtration_ rate heart hypertension diabetes mellitus myocardial_ infarction
cRT systolic_ dysfunction resynchronization_reverses_remodeling Systolic_ left_ v_entricular_ dysfunction left ventricularLV ejection_fractionLVEF
β1ARs s1PR1s myocyte cAMP receptors g-protein-coupled receptor_ kinase
PAf-cp PAf lyso-paf-AT pp-PLA2
aUC
Rate-control cardiac procedures cardioversions costs antiarrhythmic drugs c
spironolactone hospitalization
diabetes mellitus cardiomyopathy β-blocker angiotensin-converting enzyme_ inhibitor angiotensin_II receptor_blocker
epleren_Post_myocardial_ infarction_ Heart_ failure efficacy edgeSUS post-myocardial_ infarction heart_ failure aldosterone_ antagonist epleren
cardiopulmanary_ exercise_ rehabilitation patients_ with_chron_ heart_ failure chf CardioPulmonary_ Exercise_ Testing cPET exercise_ rehabilitation
risk_reduction h heart_ failure_related_ mortality
DASh_sRD brachial_synchrone_synchrone_tension central_en-systolic_tension hg
all-cause_ mortality HF LVEF Heart_ Failure_ Survey ISrael
HF obese body_ mass_ index black ethnicity idiopathic-dilated_ cardiomyopathy
ventricular_ ejection_fraction World_ Health Organization idiopathic_ dilated_ cardiomyopathy negative coronary_ angiography
European Society_of_ Cardiology hfff heart_ failure LV ejection_fraction_de_a_non-dilated_ left_ventricle diastolic_ dysfunction implantation LV diastolic_ stiffness LV filling
glomerular_ filtration egf diabetes cholesterol lDL-cholesterol CLCNka_GG
echocardiography LV end-diastolic_dimension LV end-diastolic_tension_de_wall_ stress lung_ weight aCF sham
heart_ failure ejection_fraction cardiac_ rehabilitation_care Nordic_ walking
dRS-stratified hazard ratios sitagliptin pioglitazone sitagliptin sulfonylureas sitagliptin insulin
skeletal_puissance t-score figure sarcopenic_ range_de_puissance
RAS- β-blocker_uptitrations all-cause_ mortality hff hf
testosterone oxygen_uptake Beck_depression inventory leg_ strength Medical
Heart_ Failure h-action social_ support score pss btes
ST2 cardiovascular_ death HF mortality
New York_ Heart_association cardiopulmonary_ exercise lean_ mass dXA calf_ muscle magnetic_réonance_ spectroscopy
low-dose dopamine nesiritide diuretic therapy renal
cRT New York_ Heart_association heart_ failure left ventricular_ ejection QRs echocardiographic ventricular_ dyssynchrony
ventricularLV ejection fraction HF right-side_ cardiac catheterization transthoracic echocardiography transmitral_ flow mitral_ annulus diastole
acute_ coronary syndromes CAD bNP NT-probNP CAD
hf lyso-paf-AT PAf-cp PAf-AH lp-PLA2
sternotomy aortic_ valve bioprosthetic valve_ replacement dacron patch_closure aortic_ valve transcatheter aortic_ valve
plasma_n-terminal pro-b-type_ natriuretic_peptideNT-probNP acute_ heart_ failureHF emergency department ed
cardiac_ troponin t ctnt n-terminal_pro-b-type_natriuretic_peptideNT-probNP HF HF Atherosclerosis_ Risk_in_comunisARI
body_ mass_ index h fat-free_ mass
pd CHF cRF
reverse_ remodeling ejection_fraction mortality HF dialysis
EH LV_contractility hz LVf expression_de_tension end-systolic_ volume hg
echocardiography dilated LV end-diastolic volume_ index ml ejection_fraction MR mitral_ valve_ opening ms mva pressure
double-blind placebo-controlled clinical_ trialROSe acute_ heart_ failure renal dysfunction glomerular filtration
BETs chromatin-mediated signal_transduction Pol II co-activation transcription_ factor_de_activation_ T cells nFAT nuclear_factor-κbNF-κb transcription_ factor
mortality hospitalization cardiovascular events myocardial infarction congestive heart_ failure arrhythmia cardiac_ death hypertension venous_thromboembolic_ events
EO-cFUs diabetes e-cfu
all-cause cardiovascular mortality
immunoblotting radioenzymatic- and fluorescence_réonance_énergie_transfer-based_assays video edge_ detection epifluorescence_microscopy l-type_ca2 myocardial_ tissues cardiomyocytes HF
Exercise_puissance oxygen_ consumptionVO2 QOL Minnesota_ Living_ with_ Heart_ Failure mlf heart_ failure
eAST atrial_ fibrillation_for_ Stroke_prevention_trial AF stroke
ventricular_éjection_fraction patients HF ventricular_éjection_fraction hospital acute_ outpatients
TAC-induce_proteomic alterations mitochondrial-targeted_peptide SS31 perturbed_ mitochondrial_fonctionnement TAC mitochondrial-targeted_peptide_ drugs heart_ failure
hf ventricularLV ejection_fraction hpf echo-Doppler pro-brain-type_natriuretic_peptide
low-volume eds
hABC Battery_ scores Health ABC HF Risk_Model discrimination c-indexnet-reclassification-improvement HF
cardiac transplant ECCT diabetes mellitus chronic_ kidney disease glomerular_ filtration
cf msea Self-Care_ Maintenance_ Scale cf msea Self-Care_management_ Scale cf msea Self-Care_conversion_ scale
BAT distance_ walked quality-of-life
preoperative hypoalbuminemia postoperative_ normalization_de_albumin_ levels lVAD
rehospitalization acute_méocardial_ infarction am kidney infection urinary_ tract infectionUTI
heart_ failureHF ischemic_nonischemic_ cardiomyopathies pharmacological implantable implantable cardioverter_defibrillateurs cardiac resynchronization_therapy cardiac transplantation ventricular_assist devices
SAF PF figure_de_caheterization central_venous_tension hg sVR dyn cardiac
admission_median_bNP EF bNP bp
heart_ failure implantationLV_assist_ device death
LV ejection_fraction vitesse_de_ circumferential_ shortening systolic elastance contractile_ efficiency aCF aCF allopurinol rats o2 consumption_ rate cardiomyocytes extracellular flux
HFpEF LV_ structure normal_geometry LV hypertrophyLVh wall_ thickness cr LVh RWT vh
angion_ receptor_prilysin_ inhibitor neprilysin_ inhibitor_prodrug angiotensin_ receptor_ antagonist_ valsartan hypertension heart_ failure
blood_tension mitral valve plasty degenerative MR p3 chordal ruptures angle-to-edge anastomosis ring_ annuloplasty Physio Ring edwards_lifesciences irvine
shuttle_walk_test oxygen_uptake muscular_ strength echocardiographic measures pro-brain natriuretic_peptide depression beck_depression_inventory minnesota_ Living_with_ Heart_ Failure Medical
LVEF long-term_ mortality LVEF
généra-Kyoto lean ZSF obese ZSF obese ZSF high-fat_diet metabolic renal echocardiographic evaluations hemodynamically
Kaplan-meier_curves log-rank
af af hypertension sinus rhythmhazard
HF-ref NYHA_ functional_ class_ II egf potassium eplerenone hyperkalemia WRF
ffffff body_ffréquence_distribution dual_énergie_ X-ray_ absorptiometry dXA non-diabetic patients chronic_ heart_ failurecccc non-cachectic CHF myocardial_ infarction-both
spironolactone end point_de_ death hospitalization HF AAs
pulmonary_ arterial_ hypertension inoperable chronic thromboembolic pulmonary_ hypertension impaired ventricular_puissance pulmonary_ arterial_ hypertension medication stress echocardiography cardiopulmonary_ exercise
cardiovascular_ death HF btes btes cardiovascular_ death HF
index_de_fréquence_de_fréquence_de_la_fréquence_de_la_fréquence_de_la_fréquence_de_la_fréquence_de_cause_de_la_fréquence
implantable implantable_ cardioverter-de_fillator_de_activation implantation
Cardiac_ magnetic_ resonance left_ atrial_ area pulmonary_ vascular_ resistance cardiac
HF ventricular_ ejection_fraction HF New York_ Heart_association echocardiographic cardiopulmonary_ exercise
heart_ failure ABCd American_ College_of_ Cardiology acc American_ Heart_association AHA New York_ Heart_association NYHA structural_ heart_de_capitaux
mva continuity_ equationLV end-diastolic volume LV end-systolic volume mitral_ filling_ flow mva velocity_time mitral_ filling_ flow wave doppler_ echocardiography MR mitral_ valve plasty
statitistical_ significance RM mortality sts h ml office_ hours
HFPSI Ann Arbor Veterans_ Affairs HF_ clinicVA-RT VA patients HFPSI
AAs spironolactone hyperkalemia potassium hypokalemia
LVEF long-term_ mortality LVEFhazard LVEF
HFpEF HFpf genderodds ratio NYha_ class_III distance mt
echo-derived pulmonary_ arterial_ systolic_tensionPASp right ventricularRV tricuspid_ annular_ plane_synchrone_excursionTAPSe diastole end-systole heart_ failureHF cardiac
CAD diabetes electrocardiographic_q_ waves left bundle_ branch_ block nondiabetes dyslipidemia hypertension tobacco
receiver_ operating_ characteristic_curve auc PCp
trastuzumab-treated patients coronary_ artery disease hypertension
LVEF clinical_composite_ response cRT_on crte_ OFF LV_ end_synchrone_ volume_ index LV
TGF-β signaling TGF-β receptor smad small-molecule_ inhibitors c-Kit_cell_ yield epithelial mesenchymal transition markers pluripotency_ marker nanog c-Kit_cell_ differentiation cardiomyocyte
hff diuretics co-morbidities mwt NYha
HF postoperative echocardiography LV end-diastolic volume_ index LV ejection_fraction MR mitral_ valve mva pressure
implantation_fraction ivabradine SHIFT Systolic_ Heart_ Failure inhibitor_ ivabradine_trial ivabradine echocardiographic
Hazard ratios_multivariate_regression tAPse_passp hg New York_ Heart_association_fonctionnel
Renal_fonctionnel Chronic_ Kidney Disease Epidemiology glomerular_ filtration_ rate egf
paraDIGm-HF chronic_ heart_ failure systolic_ dysfunctionLV_f NYHA bNP bNPcardiovascular_ death hospitalization heart_ failure lz696 sacubiltril valsartan
hyperkalemia African_AmericansAAs as white New York_ Heart_associationNYHA HF left_ventricular_ dysfunction spironolactone aldactone_evaluationRALes
LV reverse_ remodeling pre-cRT LV ventricular ventricular
b-type_n-terminal_pro-B-type_natriuretic_peptide coronary_ artery disease bnp p ventricular_ cardiomyocytes ventricular_fréquence_ stress myocardial_ischemia
iRS1 iRS2 heart hyperinsulinemia myocardial_ insulin_ resistance cellular_ dysfunction iRS2 heart-specific iRS2 double-knockout h-dKO liver-specific iRS2 double-knockout l-dKO
angiotensin-converting enzyme inhibitorsangiotensin receptor_blockers β-blockers
ivabradine
liberal transfusion mortality
risk_de_ death unplanned_ readmission
hEK embryonic_ kidney sphingosine_-1-phosphate s1PR1 downregulation isoproterenol β-adrenergic receptor_ agonist
Kansas City Cardiomyopathy Minnesota Heart_ Failure depressive_ symptoms beck_depression inventory depression natriuretic_peptide endothelial_fréquence-mediated_ dilatation ventricular_diastolique
cardiovascular events atrial_ fibrillation left ventricular_ ejection_fraction diabetes mellitus peripheral_ vascular disease myocardial infarction heart_ failure stroke glomerular_ filtration
in_conjunction diastolic_fonctionnement ventricular-arterial coupling
disease_risk score dRS saxagliptin sitagliptin saxagliptin pioglitazone saxagliptin sulfonylureas
revascularization coronary_ artery_ bypass surgery hazard ratio percutaneous_ coronary intervention systolic_ blood_tension left bundle_ branch_ block_ pattern baseline_ electrocardiogram
biomedical treatment CHm ventricular_éjection_fraction left ventricular_ diastolic_ end_ diameter
heart_ failure ventricular_ ejection_fraction Arg_gn27 gl27_haplotype β2-receptor carvedilol metoprolol
low-volume_de_hospitalization ed
health_budy_program risk-adjusted_ all-cause_ mortalityhazard ratio hz inpatient_admissions
multivariable-adjusted_ hazard ratios Mediterranean_diet
ctnt NT-probNP aric_fh systolic_ blood_tension antihypertensive medication smoking diabetes coronary_heart_ disease heart_ rate HF receiver_ operating_ characteristic_curve discrimination nRI
eplerenone hyperkalemia renal_fonctionnement wRF EMPHASIS-HF heart_ failure ejection_fraction h-ref New York Heart_association NYHA glomerular_ filtration_ rate egf serum_potassium
low-dose_ nesiritide cumulative_ urine_ volumenesiritide
Nordic_ walking_de_fonctionnement mt physical_ activity right_ grip depressive
hyperkalemia WRF diabetes egf systolic_ blood_tension hg potassium hyperkalemiadrug_discontinuation hospitalization WRF HF cardiovascular mortality
PAf biosynthetic_ enzymeslyso-paf acetyltransferaselyso-paf-at dithiothreitol dt-insensitive CDp_ choline_phosphotransferase pf-cp catabolic_ isoenzymes pf-acetylhydrolase pf-AH lipoprotein-associated_phospholipase lp-PLA
ivabradine_group follow-up_ exercise_induce
CHF ods_ration hct chest radiation hypertension NAD_h-oxidase subunit_RAC2 hf doxorubicin_efflux_ transporter
NYHA classification class_III class_ II patient quality_of_ life Duke_ Activity_status_ Index Kansas_City_ Cardiomyopathy_ Questionnaire
low-dose_ dopamine cumulative_ urine_ volumedopamine
fréquence hz figure baseline_ glomerular_ filtration hz chronic_ obstructive_ pulmonary disease diabetes ventricular_ ejection_fraction fraction iCD_ shocks New York_ Heart_association atrial_ fibrillation congestive_HF
oxygen_uptake hazard ratio ventilatory_ efficiency slope hemoglobin ventricular_ ejection_fraction renal
Kansas_city_cardiomyopathy_ Questionnaire Minnesota_ Living_ with_ Heart_ Failure questionsnaire Beck_depression inventory Zung flow-mediated_dilatation_ diameter Fes natriuretic_peptide mitral_e_ wave
